The retained functionality of the sodium iodide symporter (NIS) expressed in differentiated thyroid cancer (DTC) cells allows the further utilization of post-surgical radioactive iodine (RAI) therapy, which is an effective treatment for reducing the risk of recurrence, and even the mortality, of DTC. Whereas, the dedifferentiation of DTC could influence the expression of functional NIS, thereby reducing the efficacy of RAI therapy in advanced DTC. Genetic alternations (such as BRAF and the rearranged during transfection [RET]/papillary thyroid cancer [PTC] rearrangement) have been widely reported to be prominently responsible for the onset, progression, and dedifferentiation of PTC, mainly through activating the mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase (PI3K) signaling cascades. These genetic alternations have been suggested to associate with the reduced expression of iodide-handling genes in thyroid cancer, especially the NIS gene, disabling iodine uptake and causing resistance to RAI therapy. Recently, novel and promising approaches aiming at various targets have been attempted to restore the expression of these iodine-metabolizing genes and enhance iodine uptake through in vitro studies and studies of RAI-refractory (RAIR)-DTC patients. In this review, we discuss the regulation of NIS, known mechanisms of dedifferentiation including the MAPK and PI3K pathways, and the current status of redifferentiation therapy for RAIR-DTC patients.

Citations

Citations to this article as recorded by  

• Long-term impact of prophylactic central neck dissection in non-invasive classic papillary thyroid carcinoma
  Zehang Xu, Zhuochao Mao, Shitu Chen, Zhe Mo, Jie Zhou, Zhendong Chen, Rasa Zarnegar, Thomas J. Fahey III, Weibin Wang, Lisong Teng
  European Journal of Surgical Oncology.2024; 50(1): 107305.     CrossRef
• The role of MAPK, notch and Wnt signaling pathways in papillary thyroid cancer: Evidence from a systematic review and meta-analyzing microarray datasets employing bioinformatics knowledge and literature
  Elham Amjad, Solmaz Asnaashari, Ali Jahanban-Esfahlan, Babak Sokouti
  Biochemistry and Biophysics Reports.2024; 37: 101606.     CrossRef
• Diagnostic Performance of [18F]TFB PET/CT Compared with Therapeutic Activity [131I]Iodine SPECT/CT and [18F]FDG PET/CT in Recurrent Differentiated Thyroid Carcinoma
  David Ventura, Matthias Dittmann, Florian Büther, Michael Schäfers, Kambiz Rahbar, Daniel Hescheler, Michael Claesener, Philipp Schindler, Burkhard Riemann, Robert Seifert, Wolfgang Roll
  Journal of Nuclear Medicine.2024; 65(2): 192.     CrossRef
• Dihydrotanshinone I exhibits antitumor effects via β-catenin downregulation in papillary thyroid cancer cell lines
  Elisabetta Molteni, Federica Baldan, Giuseppe Damante, Lorenzo Allegri
  Scientific Reports.2024;[Epub]     CrossRef
• Targeting DUSP5 suppresses malignant phenotypes of BRAF-mutant thyroid cancer cells and improves their response to sorafenib
  Pu Chen, Jianling Wang, Yao Yao, Yiping Qu, Meiju Ji, Peng Hou
  Endocrine.2024;[Epub]     CrossRef
• Lipid‐Peptide‐mRNA Nanoparticles Augment Radioiodine Uptake in Anaplastic Thyroid Cancer
  Qinglin Li, Lizhuo Zhang, Jiayan Lang, Zhuo Tan, Qingqing Feng, Fei Zhu, Guangna Liu, Zhangguo Ying, Xuefei Yu, He Feng, Heqing Yi, Qingliang Wen, Tiefeng Jin, Keman Cheng, Xiao Zhao, Minghua Ge
  Advanced Science.2023;[Epub]     CrossRef
• Case Report: Regaining radioiodine uptake following PRRT in radioiodine-refractory thyroid cancer: A new re-differentiation strategy?
  Bentolhoda Hadad, Emran Askari, Seyed Rasoul Zakavi, Kamran Aryana, Soheila Erfani, Pegah Sahafi, Nima Nabavi, Atena Aghaee
  Frontiers in Nuclear Medicine.2023;[Epub]     CrossRef
• Radioiodine therapy in advanced differentiated thyroid cancer: Resistance and overcoming strategy
  Yujia Liu, Jiafeng Wang, Xiaoping Hu, Zongfu Pan, Tong Xu, Jiajie Xu, Liehao Jiang, Ping Huang, Yiwen Zhang, Minghua Ge
  Drug Resistance Updates.2023; 68: 100939.     CrossRef
• The role of miR-139-5p in radioiodine-resistant thyroid cancer
  V. Pecce, M. Sponziello, A. Verrienti, G. Grani, L. Abballe, S. Bini, S. Annunziata, G. Perotti, M. Salvatori, L. Zagaria, V. Maggisano, D. Russo, S. Filetti, C. Durante
  Journal of Endocrinological Investigation.2023; 46(10): 2079.     CrossRef
• Anti-Cancer SERCA Inhibitors Targeting Sorafenib-Resistant Human Papillary Thyroid Carcinoma
  Hang-Seok Chang, Yonjung Kim, So Young Lee, Hyeok Jun Yun, Ho-Jin Chang, Ki Cheong Park
  International Journal of Molecular Sciences.2023; 24(8): 7069.     CrossRef
• Modulation of EZH2 Activity Induces an Antitumoral Effect and Cell Redifferentiation in Anaplastic Thyroid Cancer
  Diego Claro de Mello, Kelly Cristina Saito, Marcella Maringolo Cristovão, Edna Teruko Kimura, Cesar Seigi Fuziwara
  International Journal of Molecular Sciences.2023; 24(9): 7872.     CrossRef
• Effects of apitherapy against salivary gland disorder after radioactive iodine therapy for differentiated thyroid cancer
  Kenta Nomura, Michihiro Nakayama, Atsutaka Okizaki
  Annals of Nuclear Medicine.2023; 37(8): 462.     CrossRef
• Could Oxidative Stress Play a Role in the Development and Clinical Management of Differentiated Thyroid Cancer?
  Maria Kościuszko, Angelika Buczyńska, Adam Jacek Krętowski, Anna Popławska-Kita
  Cancers.2023; 15(12): 3182.     CrossRef
• The efficacy and safety in radioactive iodine refractory thyroid cancer patients treated with sorafenib
  Yuanna Ling, Xiaoli Xiong, Jiaxin Luo, Quanliang Zou, Pan Chen, Liqin Pan, Man Long, Huijuan Feng, Wei Ouyang
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Advances in the molecular mechanism and targeted therapy of radioactive-iodine refractory differentiated thyroid cancer
  Lu Zhang, Zhi Li, Meng Zhang, Huangren Zou, Yuke Bai, Yanlin Liu, Juan Lv, Ling Lv, Pengjie Liu, Zhiyong Deng, Chao Liu
  Medical Oncology.2023;[Epub]     CrossRef
• Multicenter Randomized Double-Blind Phase III Trial of Donafenib in Progressive Radioactive Iodine-Refractory Differentiated Thyroid Cancer
  Yansong Lin, Shukui Qin, Hui Yang, Feng Shi, Aimin Yang, Xingmin Han, Bin Liu, Zhiyong Li, Qinghai Ji, Lijun Tang, Zhiyong Deng, Yong Ding, Wei Fu, Xianhe Xie, Linfa Li, Xiaohui He, Zhongwei Lv, Qingjie Ma, Zan Shen, Zhuming Guo, Zhendong Chen, Yali Cui,
  Clinical Cancer Research.2023; 29(15): 2791.     CrossRef
• A review of Glycogen Synthase Kinase-3 (GSK3) inhibitors for cancers therapies
  Riya Thapa, Gaurav Gupta, Asif Ahmad Bhat, Waleed Hassan Almalki, Sami I. Alzarea, Imran Kazmi, Shakir Saleem, Ruqaiyah Khan, Najla Altwaijry, Harish Dureja, Sachin Kumar Singh, Kamal Dua
  International Journal of Biological Macromolecules.2023; 253: 127375.     CrossRef
• Discovery of New Anti-Cancer Agents against Patient-Derived Sorafenib-Resistant Papillary Thyroid Cancer
  Yuna Kim, Hyeok Jun Yun, Kyung Hwa Choi, Chan Wung Kim, Jae Ha Lee, Raymond Weicker, Seok-Mo Kim, Ki Cheong Park
  International Journal of Molecular Sciences.2023; 24(22): 16413.     CrossRef
• Utilizing CD44v6 and V600EBRAF-mutation for in vitro targeted combination therapy of thyroid carcinomas
  A.C.L. Mortensen, J. Imgenberg-Kreuz, D. Spiegelberg, J. Botling, M. Nestor
  Heliyon.2023; 9(12): e22594.     CrossRef
• Canine follicular cell and medullary thyroid carcinomas: Immunohistochemical characterization
  Jana Jankovic, Eve Tièche, Martina Dettwiler, Kerstin Hahn, Stephanie Scheemaeker, Martin Kessler, Sylvie Daminet, Sven Rottenberg, Miguel Campos
  Veterinary Pathology.2023;[Epub]     CrossRef
• Advancements in theranostic applications: exploring the role of fibroblast activation protein inhibition tracers in enhancing thyroid health assessment
  Yuhua Wang, Ye Liu, Huixia Geng, Wanchun Zhang
  EJNMMI Research.2023;[Epub]     CrossRef
• Tyrosine Kinase Inhibitors for Radioactive Iodine Refractory Differentiated Thyroid Cancer
  Christos Cortas, Haris Charalambous
  Life.2023; 14(1): 22.     CrossRef
• microRNA-181a promotes the oncogene S100A2 and enhances papillary thyroid carcinoma growth by mediating the expression of histone demethylase KDM5C
  Y. Wang, H. Ye, Y. Yang, J. Li, A. Cen, L. Zhao
  Journal of Endocrinological Investigation.2022; 45(1): 17.     CrossRef
• Systemic Therapy in Thyroid Cancer
  Amit Kumar Agrawal, Vanita Noronha, Vijay Patil, Nandini Menon, Akhil Kapoor, Anuradha Chougule, Pratik Chandrani, Kumar Prabhash
  Indian Journal of Surgical Oncology.2022; 13(1): 68.     CrossRef
• Small activating RNA-activated NIS gene promotes 131I uptake and inhibits thyroid cancer via AMPK/mTOR pathway
  Li Jia, Yan Chen, Fukun Chen, Juan Lv, Yanling Li, Fei Hou, Zhixian Yang, Zhiyong Deng
  Pathology - Research and Practice.2022; 229: 153735.     CrossRef
• Effects of Anti-Cancer Drug Sensitivity-Related Genetic Differences on Therapeutic Approaches in Refractory Papillary Thyroid Cancer
  Hyeok Jun Yun, Minki Kim, Sang Yong Kim, Sungsoon Fang, Yonjung Kim, Hang-Seok Chang, Ho-Jin Chang, Ki Cheong Park
  International Journal of Molecular Sciences.2022; 23(2): 699.     CrossRef
• Comprehensive Analysis of the Prognosis and Drug Sensitivity of Differentiation-Related lncRNAs in Papillary Thyroid Cancer
  Wenlong Wang, Ning Bai, Xinying Li
  Cancers.2022; 14(5): 1353.     CrossRef
• American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatment
  David C. Shonka, Alan Ho, Ashish V. Chintakuntlawar, Jessica L. Geiger, Jong C. Park, Nagashree Seetharamu, Sina Jasim, Amr H. Abdelhamid Ahmed, Keith C. Bible, Marcia S. Brose, Maria E. Cabanillas, Kirsten Dabekaussen, Louise Davies, Dora Dias‐Santagata,
  Head & Neck.2022; 44(6): 1277.     CrossRef
• State of the Art in the Current Management and Future Directions of Targeted Therapy for Differentiated Thyroid Cancer
  Horatiu Silaghi, Vera Lozovanu, Carmen Emanuela Georgescu, Cristina Pop, Bogdana Adriana Nasui, Adriana Florinela Cătoi, Cristina Alina Silaghi
  International Journal of Molecular Sciences.2022; 23(7): 3470.     CrossRef
• Targeting GLI1 Transcription Factor for Restoring Iodine Avidity with Redifferentiation in Radioactive-Iodine Refractory Thyroid Cancers
  Ji Min Oh, Ramya Lakshmi Rajendran, Prakash Gangadaran, Chae Moon Hong, Ju Hye Jeong, Jaetae Lee, Byeong-Cheol Ahn
  Cancers.2022; 14(7): 1782.     CrossRef
• The Role of the Kinase Inhibitors in Thyroid Cancers
  Francesca Cuomo, Claudio Giani, Gilda Cobellis
  Pharmaceutics.2022; 14(5): 1040.     CrossRef
• In Silico Screening and Validation of PDGFRA Inhibitors Enhancing Radioiodine Sensitivity in Thyroid Cancer
  Xuefei Yu, Xuhang Zhu, Lizhuo Zhang, Jiang-Jiang Qin, Chunlai Feng, Qinglin Li
  Frontiers in Pharmacology.2022;[Epub]     CrossRef
• Clinical and prognosis value of the number of metastatic lymph nodes in patients with papillary thyroid carcinoma
  Ling Zhan, Hong-fang Feng, Xi-zi Yu, Ling-rui Li, Jun-long Song, Yi Tu, Jing-ping Yuan, Chuang Chen, Sheng-rong Sun
  BMC Surgery.2022;[Epub]     CrossRef
• Radionuclide 131I-labeled albumin-indocyanine green nanoparticles for synergistic combined radio-photothermal therapy of anaplastic thyroid cancer
  Xuemei Zhang, Ziyu Yan, Zhaowei Meng, Ning Li, Qiang Jia, Yiming Shen, Yanhui Ji
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Re-evaluation of the role of autophagy in thyroid cancer treatment
  Darya Kazakova, Mika Shimamura, Tomomi Kurashige, Koichiro Hamada, Yuji Nagayama
  Endocrine Journal.2022; 69(7): 847.     CrossRef
• Radiopharmaceutical Treatments for Cancer Therapy, Radionuclides Characteristics, Applications, and Challenges
  Suliman Salih, Ajnas Alkatheeri, Wijdan Alomaim, Aisyah Elliyanti
  Molecules.2022; 27(16): 5231.     CrossRef
• Potential Therapeutic Agents against Paclitaxel—And Sorafenib-Resistant Papillary Thyroid Carcinoma
  Seok-Mo Kim, Keunwan Park, Jin Hong Lim, Hyeok Jun Yun, Sang Yong Kim, Kyung Hwa Choi, Chan Wung Kim, Jae Ha Lee, Raymond Weicker, Cheol-Ho Pan, Ki Cheong Park
  International Journal of Molecular Sciences.2022; 23(18): 10378.     CrossRef
• Research Progress of BRAF V600E Gene Mutation in Papillary Thyroid Carcinoma
  延泽 刘
  Advances in Clinical Medicine.2022; 12(09): 8499.     CrossRef
• Sinomenine Hydrochloride Promotes TSHR-Dependent Redifferentiation in Papillary Thyroid Cancer
  Jing Zhang, Aomei Zhao, Xi Jia, Xinru Li, Yiqian Liang, Yan Liu, Xin Xie, Xijie Qu, Qi Wang, Yuemin Zhang, Rui Gao, Yan Yu, Aimin Yang
  International Journal of Molecular Sciences.2022; 23(18): 10709.     CrossRef
• miR-451a suppresses papillary thyroid cancer cell proliferation and invasion and facilitates apoptosis through targeting DCBLD2 and AKT1
  Jiuting Tan, Chunpu Li, Lijue Ren, Xiaohui Zhu, Fei Hua, Yuming Fu
  Molecular and Cellular Probes.2022; 66: 101863.     CrossRef
• Anxiety and depression status prior to radioactive iodine therapy among differentiated thyroid cancer patients during the COVID‑19 pandemic
  Tingting Qiao, Dingwei Gao, Junyu Tong, Yun Shen, Jiayue Ma, Zhongwei Lv, Dan Li
  Supportive Care in Cancer.2022; 30(12): 10169.     CrossRef
• Different Expression of Thyroid-Specific Proteins in Thyroid Cancer Cells between 2-Dimensional (2D) and 3-Dimensional (3D) Culture Environment
  Ji Min Oh, Prakash Gangadaran, Ramya Lakshmi Rajendran, Chae Moon Hong, Jaetae Lee, Byeong-Cheol Ahn
  Cells.2022; 11(22): 3559.     CrossRef
• Histone acetylation modifications: A potential targets for the diagnosis and treatment of papillary thyroid cancer
  Chongyang Chen, Jingfang Liu
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Effect to Therapy of Sodium-Iodine Symporter Expression by Alpha-Ray Therapeutic Agent via Sodium/Iodine Symporter
  Kazuko Kaneda-Nakashima, Yoshifumi Shirakami, Tadashi Watabe, Kazuhiro Ooe, Takashi Yoshimura, Atsushi Toyoshima, Yang Wang, Hiromitsu Haba, Koichi Fukase
  International Journal of Molecular Sciences.2022; 23(24): 15509.     CrossRef
• Reinducing Radioiodine-Sensitivity in Radioiodine-Refractory Thyroid Cancer Using Lenvatinib (RESET): Study Protocol for a Single-Center, Open Label Phase II Trial
  Maaike Dotinga, Dennis Vriens, Floris H. P. van Velden, Mette K. Stam, Jan W. T. Heemskerk, Petra Dibbets-Schneider, Martin Pool, Daphne D. D. Rietbergen, Lioe-Fee de Geus-Oei, Ellen Kapiteijn
  Diagnostics.2022; 12(12): 3154.     CrossRef
• Non-Apoptotic Programmed Cell Death in Thyroid Diseases
  Feihong Ji, Xinguang Qiu
  Pharmaceuticals.2022; 15(12): 1565.     CrossRef
• Donafenib in Progressive Locally Advanced or Metastatic Radioactive Iodine-Refractory Differentiated Thyroid Cancer: Results of a Randomized, Multicenter Phase II Trial
  Yan-Song Lin, Hui Yang, Yong Ding, Yi-Zhuang Cheng, Feng Shi, Jian Tan, Zhi-Yong Deng, Zhen-Dong Chen, Rong-Fu Wang, Qing-Hai Ji, Rui Huang, Lin-Fa Li
  Thyroid.2021; 31(4): 607.     CrossRef
• Radioactive iodine therapy may not improve disease‐specific survival in follicular variant papillary thyroid cancer without distant metastasis: A propensity score‐matched analysis
  Xiaofei Wang, Xun Zheng, Jingqiang Zhu, Zhihui Li, Tao Wei
  Head & Neck.2021; 43(6): 1730.     CrossRef
• Serum CYFRA 21.1 Level Predicts Disease Course in Thyroid Cancer with Distant Metastasis
  Chaiho Jeong, Jeongmin Lee, Hyukjin Yoon, Jeonghoon Ha, Min-Hee Kim, Ja-Seong Bae, Chan-Kwon Jung, Jeong-Soo Kim, Moo-Il Kang, Dong-Jun Lim
  Cancers.2021; 13(4): 811.     CrossRef
• Radio-Iodide Treatment: From Molecular Aspects to the Clinical View
  Antonio De la Vieja, Garcilaso Riesco-Eizaguirre
  Cancers.2021; 13(5): 995.     CrossRef
• Advances of Nanomedicine in Radiotherapy
  Wei Liu, Bo Chen, Haocheng Zheng, Yun Xing, Guiyuan Chen, Peijie Zhou, Liting Qian, Yuanzeng Min
  Pharmaceutics.2021; 13(11): 1757.     CrossRef
• Treatment Effect of Combining Lenvatinib and Vemurafenib for BRAF Mutated Anaplastic Thyroid Cancer
  Chae Moon Hong, Ji Min Oh, Prakash Gangadaran, Ramya Lakshmi Rajendran, Byeong-Cheol Ahn
  International Journal of Thyroidology.2021; 14(2): 127.     CrossRef
• TNFα-mediated activation of NF-κB downregulates sodium-iodide symporter expression in thyroid cells
  Márcia Faria, Rita Domingues, Francisca Paixão, Maria João Bugalho, Paulo Matos, Ana Luísa Silva, Salvatore Papa
  PLOS ONE.2020; 15(2): e0228794.     CrossRef
• Novel Targeted Therapies for Metastatic Thyroid Cancer—A Comprehensive Review
  Mohammad Al-Jundi, Shilpa Thakur, Sriram Gubbi, Joanna Klubo-Gwiezdzinska
  Cancers.2020; 12(8): 2104.     CrossRef
• Managing radioiodine refractory thyroid cancer: the role of dosimetry and redifferentiation on subsequent I-131 therapy
  Maaike Dotinga, Dennis Vriens, Floris van Velden, Linda Heijmen, James Nagarajah, Rodney Hicks, Ellen Kapiteijn, Lioe-Fee de Geus-Oei
  The Quarterly Journal of Nuclear Medicine and Molecular Imaging.2020;[Epub]     CrossRef
• Mediator complex subunit 16 is down-regulated in papillary thyroid cancer, leading to increased transforming growth factor-β signaling and radioiodine resistance
  Hongwei Gao, Peirong Bai, Lin Xiao, Mengjia Shen, Qiuxiao Yu, Yuanyuan Lei, Wenting Huang, Xiang Lin, Xinyi Zheng, Tao Wei, Yong Jiang, Feng Ye, Hong Bu
  Journal of Biological Chemistry.2020; 295(31): 10726.     CrossRef
• Peptide Receptor Radionuclide Therapy in Patients With Differentiated Thyroid Cancer
  Dong Yun Lee, Yong-il Kim
  Clinical Nuclear Medicine.2020; 45(8): 604.     CrossRef
• Combination of peroxisome proliferator–activated receptor gamma and retinoid X receptor agonists induces sodium/iodide symporter expression and inhibits cell growth of human thyroid cancer cells
  Jui-Yu Chen, Jane-Jen Wang, Hsin-Chen Lee, Chin-Wen Chi, Chen-Hsen Lee, Yi-Chiung Hsu
  Journal of the Chinese Medical Association.2020; 83(10): 923.     CrossRef

Nonalcoholic fatty liver disease (NAFLD) is thought to stem from the body's inability to store excess energy in adipocytes; as such, it is commonly viewed as the hepatic manifestation of metabolic syndrome. The pathogenesis of NAFLD involves ectopic fat accumulation, which also takes place in the liver, muscle and visceral fat. NAFLD is rapidly becoming more widespread in Korea, with an estimated prevalence of 30% in adults. Type 2 diabetes mellitus (T2DM) and NAFLD share insulin resistance as a common pathophysiological mechanism, and each of these two diseases affects the development of the other. Recent studies have suggested that NAFLD is often present as a comorbidity in T2DM patients. The mutual interrelationship between these conditions is shown by findings suggesting that T2DM can exacerbate NAFLD by promoting progression to nonalcoholic hepatosteatosis or fibrosis, while NAFLD causes the natural course of diabetic complications to worsen in T2DM patients. It remains unknown whether one disease is the cause of the other or vice versa. In this review, I would like to discuss current epidemiological data on the associations between NAFLD and T2DM, and how each disease affects the course of the other.

Citations

Citations to this article as recorded by  

• Effect of exercise intervention on clinical parameters in patients with non-alcoholic fatty liver disease and type 2 diabetes mellitus: a meta-analysis of randomized controlled trials
  Yu Zeng, Xuemei Zhang, Wenling Luo, Yunjian Sheng
  European Journal of Gastroenterology & Hepatology.2024; 36(1): 1.     CrossRef
• Phase 2, open-label, rollover study of cenicriviroc for liver fibrosis associated with metabolic dysfunction–associated steatohepatitis
  Sven M. Francque, Alexander Hodge, Jerome Boursier, Ziad H. Younes, Gerardo Rodriguez-Araujo, Grace S. Park, Naim Alkhouri, Manal F. Abdelmalek
  Hepatology Communications.2024;[Epub]     CrossRef
• Two-Year Therapeutic Efficacy and Safety of Initial Triple Combination of Metformin, Sitagliptin, and Empagliflozin in Drug-Naïve Type 2 Diabetes Mellitus Patients
  Young-Hwan Park, Minji Sohn, So Yeon Lee, Soo Lim
  Diabetes & Metabolism Journal.2024; 48(2): 253.     CrossRef
• Research Progress of Traditional Chinese Medicine and Western Medicine on Non-Alcoholic Fatty Liver Disease
  强江 郭
  Advances in Clinical Medicine.2024; 14(03): 561.     CrossRef
• Anti-osteoporotic treatments in the era of non-alcoholic fatty liver disease: friend or foe
  Maria Eleni Chondrogianni, Ioannis Kyrou, Theodoros Androutsakos, Christina-Maria Flessa, Evangelos Menenakos, Kamaljit Kaur Chatha, Yekaterina Aranan, Athanasios G. Papavassiliou, Eva Kassi, Harpal S. Randeva
  Frontiers in Endocrinology.2024;[Epub]     CrossRef
• Obeticholic Acid and Insulin Sensitivity in Overweight Patients with Prediabetes
  H. Amer, M. Nesim, H. Mansour, E. Nasr, N. Ahmed
  Obesity and metabolism.2024;[Epub]     CrossRef
• Utility of Indices Obtained during Medical Checkups for Predicting Fatty Liver Disease in Non-obese People
  Naoya Otsubo, Tatsuya Fukuda, Genhin Cho, Fumiaki Ishibashi, Tetsuya Yamada, Koshiro Monzen
  Internal Medicine.2023; 62(16): 2307.     CrossRef
• Liraglutide on type 2 diabetes mellitus with nonalcoholic fatty liver disease: A systematic review and meta-analysis of 16 RCTs
  Yan Zhao, Wenli Zhao, Huaien Bu, Maeda Toshiyoshi, Ye Zhao
  Medicine.2023; 102(6): e32892.     CrossRef
• Metabolic Dysfunction-Associated Fatty Liver Disease and Mortality: A Population-Based Cohort Study
  Kyung-Soo Kim, Sangmo Hong, Hong-Yup Ahn, Cheol-Young Park
  Diabetes & Metabolism Journal.2023; 47(2): 220.     CrossRef
• Metabolomics analysis reveals serum biomarkers in patients with diabetic sarcopenia
  Yuwei Tan, Xiaosong Liu, Yinping Yang, Baoying Li, Fei Yu, Wenqian Zhao, Chunli Fu, Xin Yu, Zhenxia Han, Mei Cheng
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Antagonizing apolipoprotein J chaperone promotes proteasomal degradation of mTOR and relieves hepatic lipid deposition
  Shuangdi Duan, Nong Qin, Jiayi Pi, Pei Sun, Yating Gao, Lamei Liu, Zenghui Li, Ya Li, Liyang Shi, Qiang Gao, Ye Qiu, Songqing Tang, Chun-Hsiang Wang, Tzu-Ying Chen, Sin-Tian Wang, Kung-Chia Young, Hung-Yu Sun
  Hepatology.2023; 78(4): 1182.     CrossRef
• The Influence of Metabolic Factors in Patients with Chronic Viral Hepatitis C Who Received Oral Antiviral Treatment
  Oana Irina Gavril, Radu Sebastian Gavril, Florin Mitu, Otilia Gavrilescu, Iolanda Valentina Popa, Diana Tatarciuc, Andrei Drugescu, Andrei Catalin Oprescu, Andreea Gherasim, Laura Mihalache, Irina Mihaela Esanu
  Metabolites.2023; 13(4): 571.     CrossRef
• The bidirectional relationship between NAFLD and type 2 diabetes: A prospective population-based cohort study
  Minzhen Wang, Yanan Zhao, Yingqian He, Lulu Zhang, Jing Liu, Shan Zheng, Yana Bai
  Nutrition, Metabolism and Cardiovascular Diseases.2023; 33(8): 1521.     CrossRef
• Visceral fat: A key mediator of NAFLD development and progression
  Savita Bansal, Meenakshi Vachher, Taruna Arora, Bhupender Kumar, Archana Burman
  Human Nutrition & Metabolism.2023; 33: 200210.     CrossRef
• Greater Severity of Steatosis Is Associated with a Higher Risk of Incident Diabetes: A Retrospective Longitudinal Study
  Ji Min Han, Jung Hwan Cho, Hye In Kim, Sunghwan Suh, Yu-Ji Lee, Jung Won Lee, Kwang Min Kim, Ji Cheol Bae
  Endocrinology and Metabolism.2023; 38(4): 418.     CrossRef
• The role of TRIM family in metabolic associated fatty liver disease
  Jingyue Zhang, Yingming Zhang, Ze Ren, Dongmei Yan, Guiying Li
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Non-alcoholic fatty liver disease and diabetic retinopathy: Is there an association?
  Mathew Jacob, Mary Joseph, Jyothi Idiculla
  Journal of Family Medicine and Primary Care.2023; 12(9): 2028.     CrossRef
• Camel whey protein improves diabetic liver injury by targeting ACMSD and promoting de novo NAD+ synthesis
  Zhihua Dou, Huaibin Yao, Yutong Xie, Ying Liu, Yang Gao, Jie Yang
  Journal of Functional Foods.2023; 110: 105835.     CrossRef
• Gut microbiota and nonalcoholic fatty liver disease
  Boyeon Kim, Bukyung Kim
  Kosin Medical Journal.2023; 38(3): 169.     CrossRef
• Non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus
  E.G. Mankieva, E.I. Kukhareva
  Dokazatel'naya gastroenterologiya.2023; 12(4): 103.     CrossRef
• Body Fat Distribution, Glucose Metabolism, and Diabetes Status Among Older Adults: The Multiethnic Cohort Adiposity Phenotype Study
  Gertraud Maskarinec, Phyllis Raquinio, Bruce S. Kristal, Adrian A. Franke, Steven D. Buchthal, Thomas M. Ernst, Kristine R. Monroe, John A. Shepherd, Yurii B. Shvetsov, Loïc Le Marchand, Unhee Lim
  Journal of Epidemiology.2022; 32(7): 314.     CrossRef
• Evaluation of the reciprocal interaction between hepatic steatosis and type 2 diabetes: a comparative analysis with respect to anti-diabetic treatment, glycemic control, renal and hepatic function
  Teslime Ayaz, Hatice Beyazal Polat, Bilgesah Kilictas
  International Journal of Diabetes in Developing Countries.2022; 42(3): 421.     CrossRef
• Glycemic control, the unconsidered outcome in the treatment of nonalcoholic fatty liver disease
  Diego García-Compeán, Emanuela Orsi, Tsutomu Nishida, Ramesh Kumar
  Annals of Hepatology.2022; 27(1): 100648.     CrossRef
• Prevalence of High and Moderate Risk Nonalcoholic Fatty Liver Disease Among Adults in the United States, 1999–2016
  Pegah Golabi, James M. Paik, Michael Harring, Elena Younossi, Khaled Kabbara, Zobair M. Younossi
  Clinical Gastroenterology and Hepatology.2022; 20(12): 2838.     CrossRef
• The Influence of Obesity and Metabolic Health on Vascular Health
  Eun-Jung Rhee
  Endocrinology and Metabolism.2022; 37(1): 1.     CrossRef
• Lifestyle as well as metabolic syndrome and non-alcoholic fatty liver disease: an umbrella review of evidence from observational studies and randomized controlled trials
  Xiaojuan Peng, Juan Li, Hailiang Zhao, Junlong Lai, Junqin Lin, Shaohui Tang
  BMC Endocrine Disorders.2022;[Epub]     CrossRef
• The Impact of Insulin Resistance on Hepatic Fibrosis among United States Adults with Non-Alcoholic Fatty Liver Disease: NHANES 2017 to 2018
  Ji Cheol Bae, Lauren A. Beste, Kristina M. Utzschneider
  Endocrinology and Metabolism.2022; 37(3): 455.     CrossRef
• Extra-Glycemic Effects of Anti-Diabetic Medications: Two Birds with One Stone?
  Eun-Jung Rhee
  Endocrinology and Metabolism.2022; 37(3): 415.     CrossRef
• Structurally‐engineered fatty acid 1024 (SEFA‐1024) improves diet‐induced obesity, insulin resistance, and fatty liver disease
  Jordon D. Secor, Bennet S. Cho, Lumeng J. Yu, Amy Pan, Victoria H. Ko, Duy T. Dao, Michael Feigh, Lorenzo Anez‐Bustillos, Gillian L. Fell, David A. Fraser, Kathleen M. Gura, Mark Puder
  Lipids.2022; 57(4-5): 241.     CrossRef
• Impact of COVID-19 Lockdown on Non-Alcoholic Fatty Liver Disease and Insulin Resistance in Adults: A before and after Pandemic Lockdown Longitudinal Study
  Ángel Arturo López-González, Bárbara Altisench Jané, Luis Masmiquel Comas, Sebastiana Arroyo Bote, Hilda María González San Miguel, José Ignacio Ramírez Manent
  Nutrients.2022; 14(14): 2795.     CrossRef
• Captopril and Spironolactone can Attenuate Diabetic Nephropathy in Wistar Rats by Targeting ABCA1 and microRNA-33
  Tina Ghaffari, Nariman Moradi, Elham Chamani, Zahra Ebadi, Reza Fadaei, Shahin Alizadeh-Fanalou, Sahar Yarahmadi, Soudabeh Fallah
  Current Pharmaceutical Design.2022; 28(16): 1367.     CrossRef
• Elevated serum γ-glutamyl transferase is associated with low muscle function in adults independent of muscle mass
  Seunghyun Lee, Dawon Song, Sungjae Shin, Namki Hong, Yumie Rhee
  Nutrition.2022; 103-104: 111813.     CrossRef
• Cross-sectional association between prolactin levels and non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus: a retrospective analysis of patients from a single hospital in China
  Yuanyuan Zhang, Huaizhen Liu
  BMJ Open.2022; 12(10): e062252.     CrossRef
• Non-invasive screening, staging and management of metabolic dysfunction-associated fatty liver disease (MAFLD) in type 2 diabetes mellitus patients : what do we know so far ?
  Q Binet, A Loumaye, V Preumont, J-P Thissen, M.P. Hermans, N Lanthier
  Acta Gastro Enterologica Belgica.2022; 85(2): 346.     CrossRef
• Diosgenin Ameliorated Type II Diabetes-Associated Nonalcoholic Fatty Liver Disease through Inhibiting De Novo Lipogenesis and Improving Fatty Acid Oxidation and Mitochondrial Function in Rats
  Yujie Zhong, Zhiman Li, Ruyi Jin, Yanpeng Yao, Silan He, Min Lei, Xin Wang, Chao Shi, Li Gao, Xiaoli Peng
  Nutrients.2022; 14(23): 4994.     CrossRef
• Correlation between Component Factors of Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome in Nurses: An Observational and Cross-Sectional Study
  Wen-Pei Chang, Yu-Pei Chang
  International Journal of Environmental Research and Public Health.2022; 19(23): 16294.     CrossRef
• Recent advances and potentiality of postbiotics in the food industry: Composition, inactivation methods, current applications in metabolic syndrome, and future trends
  Yujie Zhong, Tao Wang, Ruilin Luo, Jiayu Liu, Ruyi Jin, Xiaoli Peng
  Critical Reviews in Food Science and Nutrition.2022; : 1.     CrossRef
• Holistic analysis of hepatosteatosis literature: a scientometric study of global hepatosteatosis publications between 1980 and 2019
  Fatih ESKİN, Engin ŞENEL
  Journal of Medicine and Palliative Care.2022; 3(4): 300.     CrossRef
• Terpenoids: Natural Compounds for Non-Alcoholic Fatty Liver Disease (NAFLD) Therapy
  Pengyu Yao, Yajuan Liu
  Molecules.2022; 28(1): 272.     CrossRef
• Association of Non-Alcoholic Fatty Liver Dis-ease and Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus: a Cross-Sectional Study
  Zahra Heidari, Zahra Sharafi
  Iranian South Medical Journal.2022; 25(1): 30.     CrossRef
• Race and Ethnicity in Non-Alcoholic Fatty Liver Disease (NAFLD): A Narrative Review
  Kiarash Riazi, Mark G. Swain, Stephen E. Congly, Gilaad G. Kaplan, Abdel-Aziz Shaheen
  Nutrients.2022; 14(21): 4556.     CrossRef
• MAFLD vs. NAFLD: shared features and potential changes in epidemiology, pathophysiology, diagnosis, and pharmacotherapy
  Ying-Xin Xian, Jian-Ping Weng, Fen Xu
  Chinese Medical Journal.2021; 134(1): 8.     CrossRef
• Factors associated with elevated alanine aminotransferase in employees of a German chemical company: results of a large cross-sectional study
  Matthias Claus, Christoph Antoni, Bernd Hofmann
  BMC Gastroenterology.2021;[Epub]     CrossRef
• Treatment potential of LPCN 1144 on liver health and metabolic regulation in a non-genomic, high fat diet induced NASH rabbit model
  P. Comeglio, E. Sarchielli, S. Filippi, I. Cellai, G. Guarnieri, A. Morelli, G. Rastrelli, E. Maseroli, S. Cipriani, T. Mello, A. Galli, B. J. Bruno, K. Kim, K. Vangara, K. Papangkorn, N. Chidambaram, M. V. Patel, M. Maggi, L. Vignozzi
  Journal of Endocrinological Investigation.2021; 44(10): 2175.     CrossRef
• Cellular protein markers, therapeutics, and drug delivery strategies in the treatment of diabetes-associated liver fibrosis
  Chien-Yu Lin, Pratik Adhikary, Kun Cheng
  Advanced Drug Delivery Reviews.2021; 174: 127.     CrossRef
• Trend for Clinical Use of Metabolic Associated Fatty Liver Disease (MAFLD)
  Hiroshi Bando
  Asploro Journal of Biomedical and Clinical Case Reports.2021; 4(2): 99.     CrossRef
• Prediction of Cardiovascular Risk Using Nonalcoholic Fatty Liver Disease Scoring Systems
  Ye-Na Kweon, Hae-Jin Ko, A-Sol Kim, Hye-In Choi, Ji-Eun Song, Ji-Yeon Park, Sung-Min Kim, Hee-Eun Hong, Kyung-Jin Min
  Healthcare.2021; 9(7): 899.     CrossRef
• Melatonin ameliorates hepatic steatosis by inhibiting NLRP3 inflammasome in db/db mice
  Yongxiang Yu, Dongru Chen, Yuhua Zhao, Jianjun Zhu, Xiaohui Dong
  International Journal of Immunopathology and Pharmacology.2021; 35: 205873842110368.     CrossRef
• Non-Alcoholic Fatty Liver Disease and Its Association With Diabetes Mellitus
  Jaskamal Padda, Khizer Khalid, Anwar Khedr, Fahriba Tasnim, Ola A Al-Ewaidat, Ayden Charlene Cooper, Gutteridge Jean-Charles
  Cureus.2021;[Epub]     CrossRef
• Nonalcoholic fatty liver disease and the risk of insulin-requiring gestational diabetes
  Sang Youn You, Kyungdo Han, Seung-Hawn Lee, Mee Kyoung Kim
  Diabetology & Metabolic Syndrome.2021;[Epub]     CrossRef
• Serum syndecan‐4 is associated with nonalcoholic fatty liver disease
  Shu Jing Xia, Li Zhong Tang, Wen Hua Li, Zhao Shan Xu, Li Li Zhang, Feng Gan Cheng, Hong Xia Chen, Zi Hua Wang, Yu Cheng Luo, An Na Dai, Jian Gao Fan
  Journal of Digestive Diseases.2021; 22(9): 536.     CrossRef
• Non-Laboratory-Based Simple Screening Model for Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Developed Using Multi-Center Cohorts
  Jiwon Kim, Minyoung Lee, Soo Yeon Kim, Ji-Hye Kim, Ji Sun Nam, Sung Wan Chun, Se Eun Park, Kwang Joon Kim, Yong-ho Lee, Joo Young Nam, Eun Seok Kang
  Endocrinology and Metabolism.2021; 36(4): 823.     CrossRef
• Grape pomace reduces the severity of non-alcoholic hepatic steatosis and the development of steatohepatitis by improving insulin sensitivity and reducing ectopic fat deposition in mice
  Tehila Daniel, Michaella Ben-Shachar, Elyashiv Drori, Sharleen Hamad, Anna Permyakova, Elad Ben-Cnaan, Joseph Tam, Zohar Kerem, Tovit Rosenzweig
  The Journal of Nutritional Biochemistry.2021; 98: 108867.     CrossRef
• The Interplay between Insulin Resistance, Inflammation, Oxidative Stress, Base Excision Repair and Metabolic Syndrome in Nonalcoholic Fatty Liver Disease
  Sylwia Ziolkowska, Agata Binienda, Maciej Jabłkowski, Janusz Szemraj, Piotr Czarny
  International Journal of Molecular Sciences.2021; 22(20): 11128.     CrossRef
• The Leg Fat to Total Fat Ratio Is Associated with Lower Risks of Non-Alcoholic Fatty Liver Disease and Less Severe Hepatic Fibrosis: Results from Nationwide Surveys (KNHANES 2008–2011)
  Hyun Min Kim, Yong-ho Lee
  Endocrinology and Metabolism.2021; 36(6): 1232.     CrossRef
• Tip 2 Diyabet Modeli Ratların Karaciğer Dokularında Kodlanan Genlerin İfade Düzeyleri
  Lütfiye ÖZPAK, Ayfer PAZARBAŞI
  Ankara Sağlık Bilimleri Dergisi.2021; 10(1): 25.     CrossRef
• Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
  Judith Aron-Wisnewsky, Chloé Vigliotti, Julia Witjes, Phuong Le, Adriaan G. Holleboom, Joanne Verheij, Max Nieuwdorp, Karine Clément
  Nature Reviews Gastroenterology & Hepatology.2020; 17(5): 279.     CrossRef
• Non-alcoholic fatty liver disease and primary care physicians
  Ludovico Abenavoli, Anna C. Procopio, Milica Medić-Stojanoska, Francesco Luzza
  Minerva Gastroenterologica e Dietologica.2020;[Epub]     CrossRef
• The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease
  Hideki Fujii, Norifumi Kawada
  International Journal of Molecular Sciences.2020; 21(11): 3863.     CrossRef
• Active vitamin D supplementation alleviates initiation and progression of nonalcoholic fatty liver disease by repressing the p53 pathway
  Yuanyuan Liu, Mengjie Wang, Wei Xu, Hongman Zhang, Weihe Qian, Xiang Li, Xingbo Cheng
  Life Sciences.2020; 241: 117086.     CrossRef
• Serum lipoprotein(a) levels and insulin resistance have opposite effects on fatty liver disease
  Inha Jung, Hyemi Kwon, Se Eun Park, Cheol-Young Park, Won-Young Lee, Ki-Won Oh, Sung-Woo Park, Eun-Jung Rhee
  Atherosclerosis.2020; 308: 1.     CrossRef
• The effect of liraglutide on nonalcoholic fatty liver disease in type 2 diabetes mellitus
  Xueyang Zhang, Ran Bai, Yong Jia, Junwei Zong, Yongbo Wang, Yanan Dong
  International Journal of Diabetes in Developing Countries.2020; 40(4): 491.     CrossRef
• Association between Thyroid Function and Nonalcoholic Fatty Liver Disease in Euthyroid Type 2 Diabetes Patients
  Bin Huang, Shengju Yang, Shandong Ye
  Journal of Diabetes Research.2020; 2020: 1.     CrossRef
• The Absence of NLRP3-inflammasome Modulates Hepatic Fibrosis Progression, Lipid Metabolism, and Inflammation in KO NLRP3 Mice during Aging
  Paloma Gallego, Beatriz Castejón-Vega, José A. del Campo, Mario D. Cordero
  Cells.2020; 9(10): 2148.     CrossRef
• Prevalence of people at risk of developing type 2 diabetes mellitus and the involvement of community pharmacies in a national screening campaign: a pioneer action in Brazil
  Cassyano J. Correr, Wendel Coura-Vital, Josélia C. Q. P. Frade, Renata C. R. M. Nascimento, Lúbia G. Nascimento, Eliete B. Pinheiro, Wesley M. Ferreira, Janice S. Reis, Karla F. S. Melo, Roberto Pontarolo, Mônica S. A. Lenzi, José V. Almeida, Hermelinda C
  Diabetology & Metabolic Syndrome.2020;[Epub]     CrossRef
• Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease
  Kyung-Soo Kim, Byung-Wan Lee
  Clinical and Molecular Hepatology.2020; 26(4): 430.     CrossRef

• Elevated TPOAb is a Strong Predictor of Autoimmune Development in Patients of Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease: A Case–Control Study

  
  Chenyi Wang, Qianglong Niu, Haihong Lv, Qian Li, Yuping Ma, Jiaojiao Tan, Chunhua Liu
  Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2020; Volume 13: 4369.     CrossRef
• Sarcopoterium spinosum Inhibited the Development of Non-Alcoholic Steatosis and Steatohepatitis in Mice
  Ayala Wollman, Tehila Daniel, Tovit Rosenzweig
  Nutrients.2019; 11(12): 3044.     CrossRef

Branched-chain amino acids (BCAAs) are essential amino acids that are not synthesized in our body; thus, they need to be obtained from food. They have shown to provide many physiological and metabolic benefits such as stimulation of pancreatic insulin secretion, milk production, adipogenesis, and enhanced immune function, among others, mainly mediated by mammalian target of rapamycin (mTOR) signaling pathway. After identified as a reliable marker of obesity and type 2 diabetes in recent years, an increasing number of studies have surfaced implicating BCAAs in the pathophysiology of other diseases such as cancers, cardiovascular diseases, and even neurodegenerative disorders like Alzheimer's disease. Here we discuss the most recent progress and review studies highlighting both correlational and potentially causative role of BCAAs in the development of these disorders. Although we are just beginning to understand the intricate relationships between BCAAs and some of the most prevalent chronic diseases, current findings raise a possibility that they are linked by a similar putative mechanism.

Citations

Citations to this article as recorded by  

• First trimester metabolomics 1H-NMR study of the urinary profile predicts gestational diabetes mellitus development in obese women
  Cristina Piras, Isabella Neri, Roberta Pintus, Antonio Noto, Elisabetta Petrella, Francesca Monari, Angelica Dessì, Vassilios Fanos, Luigi Atzori, Fabio Facchinetti
  The Journal of Maternal-Fetal & Neonatal Medicine.2024; 35(25): 8275.     CrossRef
• Branched‐Chain Amino Acid Accumulation Fuels the Senescence‐Associated Secretory Phenotype
  Yaosi Liang, Christopher Pan, Tao Yin, Lu Wang, Xia Gao, Ergang Wang, Holly Quang, De Huang, Lianmei Tan, Kun Xiang, Yu Wang, Peter B. Alexander, Qi‐Jing Li, Tso‐Pang Yao, Zhao Zhang, Xiao‐Fan Wang
  Advanced Science.2024;[Epub]     CrossRef
• Deficiency of BCAT2-mediated branched-chain amino acid catabolism promotes colorectal cancer development
  Zi-Ran Kang, Shanshan Jiang, Ji-Xuan Han, Yaqi Gao, Yile Xie, Jinxian Chen, Qiang Liu, Jun Yu, Xin Zhao, Jie Hong, Haoyan Chen, Ying-Xuan Chen, Huimin Chen, Jing-Yuan Fang
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2024; 1870(2): 166941.     CrossRef
• Microbiome metabolite quantification methods enabling insights into human health and disease
  Jarrod Roach, Rohit Mital, Jacob J. Haffner, Nathan Colwell, Randy Coats, Horvey M. Palacios, Zongyuan Liu, Joseane L.P. Godinho, Monica Ness, Thilini Peramuna, Laura-Isobel McCall
  Methods.2024; 222: 81.     CrossRef
• Branched-chain amino acids promote occurrence and development of cardiovascular disease dependent on triglyceride metabolism via activation of the mTOR/SREBP-1/betatrophin pathway
  Jie Zhang, Ziyu Liu, Yaojun Ni, Yang Yu, Fei Guo, Yanwen Lu, Xiaoqing Wang, Hairong Hao, Shayan Li, Pan Wei, Weinan Yu, Wen Hu
  Molecular and Cellular Endocrinology.2024; 584: 112164.     CrossRef
• Heat stress reduces brown adipose tissue activity by exacerbating mitochondrial damage in type 2 diabetic mice
  Penghua Lai, Linlin Zhang, Yan Qiu, Jie Ren, Xue Sun, Ting Zhang, Liuyi Wang, Sijie Cheng, Sijia Liu, Hongli Zhuang, Daiwei Lu, Shaoliang Zhang, Huiqing Liang, Shaodong Chen
  Journal of Thermal Biology.2024; 119: 103799.     CrossRef
• Unraveling Adipose Tissue Dysfunction: Molecular Mechanisms, Novel Biomarkers, and Therapeutic Targets for Liver Fat Deposition
  Marta Lopez-Yus, Carlos Hörndler, Sofia Borlan, Vanesa Bernal-Monterde, Jose M. Arbones-Mainar
  Cells.2024; 13(5): 380.     CrossRef
• Microbial production of branched chain amino acids: Advances and perspectives
  Yanan Hao, Xuewei Pan, Jiajia You, Guomin Li, Meijuan Xu, Zhiming Rao
  Bioresource Technology.2024; 397: 130502.     CrossRef
• Maintenance of the branched-chain amino acid transporter LAT1 counteracts myotube atrophy following chemotherapy
  Stephen Mora, Olasunkanmi A. J. Adegoke
  American Journal of Physiology-Cell Physiology.2024; 326(3): C866.     CrossRef
• Metabolomics of Mice with Type 2 Diabetes and Nonalcoholic Fatty Liver Treated by Acupuncture
  Yihui Guo, Liying Zhang, Mengyuan Li, Linan Lin, Fuyu Xue, Wanning Gao, Xiaoru Xu, Haipeng Huang, Abdelilah Arredouani
  International Journal of Endocrinology.2024; 2024: 1.     CrossRef
• Metabolic Signatures Elucidate the Effect of Body Mass Index on Type 2 Diabetes
  Qiuling Dong, Sidra Sidra, Christian Gieger, Rui Wang-Sattler, Wolfgang Rathmann, Cornelia Prehn, Jerzy Adamski, Wolfgang Koenig, Annette Peters, Harald Grallert, Sapna Sharma
  Metabolites.2023; 13(2): 227.     CrossRef
• The Preventive Effect of Exercise and Oral Branched-Chain Amino Acid Supplementation on Obesity-Induced Brain Changes in Ldlr−/−.Leiden Mice
  Klara J. Lohkamp, Anita M. van den Hoek, Gemma Solé-Guardia, Maria Lisovets, Talissa Alves Hoffmann, Konstantina Velanaki, Bram Geenen, Vivienne Verweij, Martine C. Morrison, Robert Kleemann, Maximilian Wiesmann, Amanda J. Kiliaan
  Nutrients.2023; 15(7): 1716.     CrossRef
• The Crosstalk between Gut Microbiota and White Adipose Tissue Mitochondria in Obesity
  Luca Colangeli, David Israel Escobar Marcillo, Valeria Simonelli, Egidio Iorio, Tommaso Rinaldi, Paolo Sbraccia, Paola Fortini, Valeria Guglielmi
  Nutrients.2023; 15(7): 1723.     CrossRef
• Prebiotic and Probiotic Modulation of the Microbiota–Gut–Brain Axis in Depression
  Daniel E. Radford-Smith, Daniel C. Anthony
  Nutrients.2023; 15(8): 1880.     CrossRef
• Machine learning model to predict obesity using gut metabolite and brain microstructure data
  Vadim Osadchiy, Roshan Bal, Emeran A. Mayer, Rama Kunapuli, Tien Dong, Priten Vora, Danny Petrasek, Cathy Liu, Jean Stains, Arpana Gupta
  Scientific Reports.2023;[Epub]     CrossRef
• Insulin Resistance and Impaired Branched-Chain Amino Acid Metabolism in Alzheimer’s Disease
  Rui Liu, Lei Zhang, Hao You
  Journal of Alzheimer's Disease.2023; 93(3): 847.     CrossRef
• Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments
  Rexiati Ruze, Tiantong Liu, Xi Zou, Jianlu Song, Yuan Chen, Ruiyuan Xu, Xinpeng Yin, Qiang Xu
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Crosstalk between arginine, glutamine, and the branched chain amino acid metabolism in the tumor microenvironment
  Tanner J. Wetzel, Sheila C. Erfan, Lucas D. Figueroa, Leighton M. Wheeler, Elitsa A. Ananieva
  Frontiers in Oncology.2023;[Epub]     CrossRef
• Stachydrine, N‐acetylornithine and trimethylamine N‐oxide levels as candidate milk biomarkers of maternal consumption of an obesogenic diet during lactation
  Pedro Castillo, Ondrej Kuda, Jan Kopecky, Catalina Amadora Pomar, Andreu Palou, Mariona Palou, Catalina Picó
  BioFactors.2023; 49(5): 1022.     CrossRef
• Biofunctionalization of natural extracts, trends in biological activity and kinetic release
  Abraham Osiris Martínez-Olivo, Víctor Manuel Zamora-Gasga, Luis Medina-Torres, Alejandro Pérez-Larios, Sonia Guadalupe Sáyago-Ayerdi, Jorge Alberto Sánchez-Burgos
  Advances in Colloid and Interface Science.2023; 318: 102938.     CrossRef
• Muscle Traits, Sarcopenia, and Sarcopenic Obesity: A Vitamin D Mendelian Randomization Study
  Joshua P. Sutherland, Ang Zhou, Elina Hyppönen
  Nutrients.2023; 15(12): 2703.     CrossRef
• Bioactive Ingredients in Traditional Fermented Food Condiments: Emerging Products for Prevention and Treatment of Obesity and Type 2 Diabetes
  Alphonse Laya, Honoré Wangso, Iva Fernandes, Raphaël Djakba, Joana Oliveira, Eugenia Carvalho, Wen yi Kang
  Journal of Food Quality.2023; 2023: 1.     CrossRef
• Sex related differences in muscle health and metabolism in chronic obstructive pulmonary disease
  Mariëlle P.K.J. Engelen, Sarah K. Kirschner, Kimberly S. Coyle, David Argyelan, Gabriel Neal, Srinivasan Dasarathy, Nicolaas E.P. Deutz
  Clinical Nutrition.2023; 42(9): 1737.     CrossRef
• Depiction of Branched-Chain Amino Acids (BCAAs) in Diabetes with a Focus on Diabetic Microvascular Complications
  Daniela Maria Tanase, Evelina Maria Gosav, Tina Botoc, Mariana Floria, Claudia Cristina Tarniceriu, Minela Aida Maranduca, Anca Haisan, Andrei Ionut Cucu, Ciprian Rezus, Claudia Florida Costea
  Journal of Clinical Medicine.2023; 12(18): 6053.     CrossRef
• Genetic and Lifestyle-Related Factors Influencing Serum Hyper-Propionylcarnitine Concentrations and Their Association with Metabolic Syndrome and Cardiovascular Disease Risk
  Yong-Hwa Lee, Sunmin Park
  International Journal of Molecular Sciences.2023; 24(21): 15810.     CrossRef
• Relationship between Components, Intestinal Microbiota, and Mechanism of Hypoglycemic Effect of the Saggy Ink Cap Medicinal Mushroom (Coprinus Comatus, Agaricomycetes): A Review
  Wei Wang, Min Sun, Jinyan Yu, Xumin Ma, Chunchao Han
  International Journal of Medicinal Mushrooms.2023; 25(12): 81.     CrossRef
• High-protein diet with excess leucine prevents inactivity-induced insulin resistance in women
  Alessandro Mangogna, Filippo Giorgio Di Girolamo, Nicola Fiotti, Pierandrea Vinci, Matteo Landolfo, Filippo Mearelli, Gianni Biolo
  Clinical Nutrition.2023; 42(12): 2578.     CrossRef
• Exploring the functional roles of small-molecule metabolites in disease research: Recent advancements in metabolomics
  Aolei Tan, Xiaoxiao Ma
  Chinese Chemical Letters.2023; : 109276.     CrossRef
• Toward Systems-Level Metabolic Analysis in Endocrine Disorders and Cancer
  Aliya Lakhani, Da Hyun Kang, Yea Eun Kang, Junyoung O. Park
  Endocrinology and Metabolism.2023; 38(6): 619.     CrossRef
• Dietary intake of branched-chain amino acids in relation to general and abdominal obesity
  Farzaneh Asoudeh, Asma Salari-Moghaddam, Ammar Hassanzadeh Keshteli, Ahmad Esmaillzadeh, Peyman Adibi
  Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity.2022; 27(4): 1303.     CrossRef
• Tea polyphenol – gut microbiota interactions: hints on improving the metabolic syndrome in a multi-element and multi-target manner
  Hui Ma, Yaozhong Hu, Bowei Zhang, Zeping Shao, Eugeni Roura, Shuo Wang
  Food Science and Human Wellness.2022; 11(1): 11.     CrossRef
• Exogenous isoleucine can confer browning resistance on fresh-cut potato by suppressing polyphenol oxidase activity and improving the antioxidant capacity
  Zan Meng, Tong Wang, Aman Ullah Malik, Qingguo Wang
  Postharvest Biology and Technology.2022; 184: 111772.     CrossRef
• Impact of thermal treatment and fermentation by lactic acid bacteria on sorghum metabolite changes, their antioxidant and antidiabetic activities
  Fred Kwame Ofosu, Fazle Elahi, Eric Banan-Mwine Daliri, Sang-Ik Han, Deog-Hwan Oh
  Food Bioscience.2022; 45: 101502.     CrossRef
• Infant intakes of human milk branched chain amino acids are negatively associated with infant growth and influenced by maternal body mass index
  Jessica L. Saben, Clark R. Sims, Lindsay Pack, Renny Lan, Elisabet Børsheim, Aline Andres
  Pediatric Obesity.2022;[Epub]     CrossRef
• Roux-En-Y Gastric Bypass (RYGB) Surgery during High Liquid Sucrose Diet Leads to Gut Microbiota-Related Systematic Alterations
  Laimdota Zizmare, Christina N. Boyle, Sabrina Buss, Sandrine Louis, Laura Kuebler, Ketki Mulay, Ralf Krüger, Lara Steinhauer, Isabelle Mack, Manuel Rodriguez Gomez, Kristina Herfert, Yvonne Ritze, Christoph Trautwein
  International Journal of Molecular Sciences.2022; 23(3): 1126.     CrossRef
• Omics Analyses of Intestinal Microbiota and Hypothalamus Clock Genes in Circadian Disturbance Model Mice Fed with Green Tea Polyphenols
  Yuting Zhang, Lu Cheng, Yanan Liu, Ruilin Zhang, Zufang Wu, Kejun Cheng, Xin Zhang
  Journal of Agricultural and Food Chemistry.2022; 70(6): 1890.     CrossRef
• Age, Sex, Body Mass Index, Diet and Menopause Related Metabolites in a Large Homogeneous Alpine Cohort
  Vinicius Verri Hernandes, Nikola Dordevic, Essi Marjatta Hantikainen, Baldur Bragi Sigurdsson, Sigurður Vidir Smárason, Vanessa Garcia-Larsen, Martin Gögele, Giulia Caprioli, Ilaria Bozzolan, Peter P. Pramstaller, Johannes Rainer
  Metabolites.2022; 12(3): 205.     CrossRef
• α-ketoisocaproic acid promotes ER stress through impairment of autophagy, thereby provoking lipid accumulation and insulin resistance in murine preadipocytes
  Tae Jun Park, Seung Yeon Park, Hyun Jung Lee, A.M. Abd El-Aty, Ji Hoon Jeong, Tae Woo Jung
  Biochemical and Biophysical Research Communications.2022; 603: 109.     CrossRef
• The associations of serum valine with mild cognitive impairment and Alzheimer’s disease
  Yong-lan Xiong, Joseph Therriault, Shu-jiang Ren, Xiao-jun Jing, Hua Zhang
  Aging Clinical and Experimental Research.2022; 34(8): 1807.     CrossRef
• The Critical Role of the Branched Chain Amino Acids (BCAAs) Catabolism-Regulating Enzymes, Branched-Chain Aminotransferase (BCAT) and Branched-Chain α-Keto Acid Dehydrogenase (BCKD), in Human Pathophysiology
  Aikaterini Dimou, Vasilis Tsimihodimos, Eleni Bairaktari
  International Journal of Molecular Sciences.2022; 23(7): 4022.     CrossRef
• Obesity, exercise training, and BCAA supplementation: All that glitters (may not be) gold
  Stephen J. Carter, Emily B. Long, Cydne A. Perry
  Obesity.2022; 30(6): 1139.     CrossRef
• Effects of serum branched-chain amino acids on nonalcoholic fatty liver disease and subsequent cardiovascular disease
  Fei Guo, Rui Chen, Linghui Kong, Pan Wei, Ziyu Liu, Xiaoqing Wang, Hairong Hao, Yanwen Lu, Wen Hu
  Hepatology International.2022; 16(6): 1424.     CrossRef
• Advances in multi-omics study of biomarkers of glycolipid metabolism disorder
  Xinyi Fang, Runyu Miao, Jiahua Wei, Haoran Wu, Jiaxing Tian
  Computational and Structural Biotechnology Journal.2022; 20: 5935.     CrossRef
• Targeted Metabolomics Revealed a Sex-Dependent Signature for Metabolic Syndrome in the Mexican Population
  Berenice Palacios-González, Guadalupe León-Reyes, Berenice Rivera-Paredez, Isabel Ibarra-González, Marcela Vela-Amieva, Yvonne N. Flores, Samuel Canizales-Quinteros, Jorge Salmerón, Rafael Velázquez-Cruz
  Nutrients.2022; 14(18): 3678.     CrossRef
• Case report: NAFLD and maple syrup urine disease: Is there an interplay between branched-chain amino acids and fructose consumption?
  Helena Moreira-Silva, Sandra Ferreira, Manuela Almeida, Isabel Gonçalves, Maria Augusta Cipriano, J. R. Vizcaíno, Ermelinda Santos-Silva, Esmeralda Gomes-Martins
  Frontiers in Pediatrics.2022;[Epub]     CrossRef
• A self-assembled leucine polymer sensitizes leukemic stem cells to chemotherapy by inhibiting autophagy in acute myeloid leukemia
  Xi Xu, Jian Wang, Tong Tong, Wenwen Zhang, Jin Wang, Weiwei Ma, Shunqing Wang, Dunhua Zhou, Jun Wu, Linjia Jiang, Meng Zhao
  Haematologica.2022; 107(10): 2344.     CrossRef
• Effect of dietary protein content shift on aging in elderly rats by comprehensive quantitative score and metabolomics analysis
  Wenxuan Zheng, Ruiding Li, Yang Zhou, Fengcui Shi, Yao Song, Yanting Liao, Fan Zhou, Xiaohua Zheng, Jingwen Lv, Quanyang Li
  Frontiers in Nutrition.2022;[Epub]     CrossRef
• Caloric restriction improves glycaemic control without reducing plasma branched-chain amino acids or keto-acids in obese men
  M. H. Sayda, M. H. Abdul Aziz, N. Gharahdaghi, D. J. Wilkinson, P. L. Greenhaff, B. E. Phillips, K. Smith, I. Idris, P. J. Atherton
  Scientific Reports.2022;[Epub]     CrossRef
• Dietary Protein and Amino Acid Deficiency Inhibit Pancreatic Digestive Enzyme mRNA Translation by Multiple Mechanisms
  Maria Dolors Sans, Stephen J. Crozier, Nancy L. Vogel, Louis G. D’Alecy, John A. Williams
  Cellular and Molecular Gastroenterology and Hepatology.2021; 11(1): 99.     CrossRef
• Isoleucine increases muscle mass through promoting myogenesis and intramyocellular fat deposition
  Shuge Liu, Yunmei Sun, Rui Zhao, Yingqian Wang, Wanrong Zhang, Weijun Pang
  Food & Function.2021; 12(1): 144.     CrossRef
• Serum metabolomics study of women with different annual decline rates of anti-Müllerian hormone: an untargeted gas chromatography–mass spectrometry-based study
  Nazanin Moslehi, Parvin Mirmiran, Rezvan Marzbani, Hassan Rezadoost, Mehdi Mirzaie, Fereidoun Azizi, Fahimeh Ramezani Tehrani
  Human Reproduction.2021; 36(3): 721.     CrossRef
• Amino acid sensing pathway: A major check point in the pathogenesis of obesity and COVID‐19
  Aradhana Mariam Philips, Nooruddin Khan
  Obesity Reviews.2021;[Epub]     CrossRef
• The chemical mechanisms of the enzymes in the branched-chain amino acids biosynthetic pathway and their applications
  Yan-Fei Liang, Zi-Xian Long, Ya-Jian Zhang, Cai-Yun Luo, Le-Tian Yan, Wen-Yun Gao, Heng Li
  Biochimie.2021; 184: 72.     CrossRef
• Plasma Metabolomic Profiling in 1391 Subjects with Overweight and Obesity from the SPHERE Study
  Gianfranco Frigerio, Chiara Favero, Diego Savino, Rosa Mercadante, Benedetta Albetti, Laura Dioni, Luisella Vigna, Valentina Bollati, Angela Cecilia Pesatori, Silvia Fustinoni
  Metabolites.2021; 11(4): 194.     CrossRef
• Sarcopenic Obesity and Amino Acids: Concord Health and Ageing in Men Project
  David G Le Couteur, David J Handelsman, Fiona Stanaway, Louise M Waite, Fiona M Blyth, Vasi Naganathan, Robert G Cumming, Vasant Hirani, Rafael de Cabo
  The Journals of Gerontology: Series A.2021; 76(6): 1000.     CrossRef
• Metabolic signatures of greater body size and their associations with risk of colorectal and endometrial cancers in the European Prospective Investigation into Cancer and Nutrition
  Nathalie Kliemann, Vivian Viallon, Neil Murphy, Rebecca J. Beeken, Joseph A. Rothwell, Sabina Rinaldi, Nada Assi, Eline H. van Roekel, Julie A. Schmidt, Kristin Benjaminsen Borch, Claudia Agnoli, Ann H. Rosendahl, Hanna Sartor, José María Huerta, Anne Tjø
  BMC Medicine.2021;[Epub]     CrossRef
• Plasma Amino Acids and Residual Hypertriglyceridemia in Diabetic Patients Under Statins: Two Independent Cross-Sectional Hospital-Based Cohorts
  Shuang Wang, Yun-Feng Cao, Xiao-Yu Sun, Mo Hong, Zhong-Ze Fang, Hui-Huan Luo, Huan Sun, Ping Yang
  Frontiers in Cardiovascular Medicine.2021;[Epub]     CrossRef
• Identification of Metabolic Phenotypes in Young Adults with Obesity by 1H NMR Metabolomics of Blood Serum
  Khin Thandar Htun, Jie Pan, Duanghathai Pasanta, Montree Tungjai, Chatchanok Udomtanakunchai, Sirirat Chancharunee, Siriprapa Kaewjaeng, Hong Joo Kim, Jakrapong Kaewkhao, Suchart Kothan
  Life.2021; 11(6): 574.     CrossRef
• A Metabolic Pattern in Healthy Subjects Given a Single Dose of Metformin: A Metabolomics Approach
  Lina A. Dahabiyeh, Muhammad Mujammami, Tawfiq Arafat, Hicham Benabdelkamel, Assim A. Alfadda, Anas M. Abdel Rahman
  Frontiers in Pharmacology.2021;[Epub]     CrossRef
• Branched-chain Amino Acids: Catabolism in Skeletal Muscle and Implications for Muscle and Whole-body Metabolism
  Gagandeep Mann, Stephen Mora, Glory Madu, Olasunkanmi A. J. Adegoke
  Frontiers in Physiology.2021;[Epub]     CrossRef
• Identification of TBX15 as an adipose master trans regulator of abdominal obesity genes
  David Z. Pan, Zong Miao, Caroline Comenho, Sandhya Rajkumar, Amogha Koka, Seung Hyuk T. Lee, Marcus Alvarez, Dorota Kaminska, Arthur Ko, Janet S. Sinsheimer, Karen L. Mohlke, Nicholas Mancuso, Linda Liliana Muñoz-Hernandez, Miguel Herrera-Hernandez, Maria
  Genome Medicine.2021;[Epub]     CrossRef
• Antidiabetic Effect of Noodles Containing Fermented Lettuce Extracts
  Soon Yeon Jeong, Eunjin Kim, Ming Zhang, Yun-Seong Lee, Byeongjun Ji, Sun-Hee Lee, Yu Eun Cheong, Soon-Il Yun, Young-Soo Kim, Kyoung Heon Kim, Min Sun Kim, Hyun Soo Chun, Sooah Kim
  Metabolites.2021; 11(8): 520.     CrossRef
• Targeted and Untargeted Mass Spectrometry Reveals the Impact of High-Fat Diet on Peripheral Amino Acid Regulation in a Mouse Model of Alzheimer’s Disease
  Amelia L. Taylor, Don E. Davis, Simona G. Codreanu, Fiona E. Harrison, Stacy D. Sherrod, John A. McLean
  Journal of Proteome Research.2021; 20(9): 4405.     CrossRef
• The Association of 9 Amino Acids With Cardiovascular Events in Finnish Men in a 12-Year Follow-up Study
  Raimo Jauhiainen, Jagadish Vangipurapu, Annamaria Laakso, Teemu Kuulasmaa, Johanna Kuusisto, Markku Laakso
  The Journal of Clinical Endocrinology & Metabolism.2021; 106(12): 3448.     CrossRef
• Serum Metabolite Profile Associated with Sex-Dependent Visceral Adiposity Index and Low Bone Mineral Density in a Mexican Population
  Berenice Palacios-González, Guadalupe León-Reyes, Berenice Rivera-Paredez, Isabel Ibarra-González, Marcela Vela-Amieva, Yvonne N. Flores, Samuel Canizales-Quinteros, Jorge Salmerón, Rafael Velázquez-Cruz
  Metabolites.2021; 11(9): 604.     CrossRef
• Branched chain amino acids—friend or foe in the control of energy substrate turnover and insulin sensitivity?
  Elżbieta Supruniuk, Ewa Żebrowska, Adrian Chabowski
  Critical Reviews in Food Science and Nutrition.2021; : 1.     CrossRef
• Diet Effects on Cerebrospinal Fluid Amino Acids Levels in Adults with Normal Cognition and Mild Cognitive Impairment
  Kate J. Russin, K. Sreekumaran Nair, Thomas J. Montine, Laura D. Baker, Suzanne Craft
  Journal of Alzheimer's Disease.2021; 84(2): 843.     CrossRef
• QSHY Granules Promote White Adipose Tissue Browning and Correct BCAAs Metabolic Disorder in NAFLD Mice
  Binbin Zhang, Mingzhu Ni, Xiaojing Li, Qiaohong Liu, Yiyang Hu, Yu Zhao
  Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2021; Volume 14: 4241.     CrossRef
• The Changes in Endogenous Metabolites in Hyperlipidemic Rats Treated with Herbal Mixture Containing Lemon, Apple Cider, Garlic, Ginger, and Honey
  Azliana Abu Bakar Sajak, Azrina Azlan, Faridah Abas, Hazilawati Hamzah
  Nutrients.2021; 13(10): 3573.     CrossRef
• Integration of Transcriptome and Metabolome Provides Unique Insights to Pathways Associated With Obese Breast Cancer Patients
  Mohammed A. Hassan, Kaltoom Al-Sakkaf, Mohammed Razeeth Shait Mohammed, Ashraf Dallol, Jaudah Al-Maghrabi, Alia Aldahlawi, Sawsan Ashoor, Mabrouka Maamra, Jiannis Ragoussis, Wei Wu, Mohammad Imran Khan, Abdulrahman L. Al-Malki, Hani Choudhry
  Frontiers in Oncology.2020;[Epub]     CrossRef
• Omics Biomarkers in Obesity: Novel Etiological Insights and Targets for Precision Prevention
  Krasimira Aleksandrova, Caue Egea Rodrigues, Anna Floegel, Wolfgang Ahrens
  Current Obesity Reports.2020; 9(3): 219.     CrossRef
• Why Are Branched-Chain Amino Acids Increased in Starvation and Diabetes?
  Milan Holeček
  Nutrients.2020; 12(10): 3087.     CrossRef
• Differential gene signature in adipose tissue depots of growth hormone transgenic mice
  Silvana Duran‐Ortiz, Jonathan A. Young, Adam Jara, Elizabeth A. Jensen, Reetobrata Basu, Edward O. List, Yanrong Qian, John J. Kopchick, Darlene E. Berryman
  Journal of Neuroendocrinology.2020;[Epub]     CrossRef
• Prognostic Role of Serum Amino Acids in Head and Neck Cancer
  Gabriella Cadoni, Luca Giraldi, Carlo Chiarla, Jacopo Gervasoni, Silvia Persichilli, Aniello Primiano, Stefano Settimi, Jacopo Galli, Gaetano Paludetti, Dario Arzani, Stefania Boccia, Ivo Giovannini, Giovanni Almadori, Leigh A. Madden
  Disease Markers.2020; 2020: 1.     CrossRef
• Lipid changes in the metabolome of a single case study with maple syrup urine disease (MSUD) after five days of improved diet adherence of controlled branched-chain amino acids (BCAA)
  Teresa D. Douglas, L. Kristin Newby, Julie Eckstrand, Douglas Wixted, Rani H. Singh
  Molecular Genetics and Metabolism Reports.2020; 25: 100651.     CrossRef
• Branched chain amino acids, aging and age-related health
  David G. Le Couteur, Samantha M. Solon-Biet, Victoria C. Cogger, Rosilene Ribeiro, Rafael de Cabo, David Raubenheimer, Gregory J. Cooney, Stephen J. Simpson
  Ageing Research Reviews.2020; 64: 101198.     CrossRef
• Branched-chain ketoacid overload inhibits insulin action in the muscle
  Dipsikha Biswas, Khoi T. Dao, Angella Mercer, Andrew M. Cowie, Luke Duffley, Yassine El Hiani, Petra C. Kienesberger, Thomas Pulinilkunnil
  Journal of Biological Chemistry.2020; 295(46): 15597.     CrossRef

Weight loss is an important goal in the management of several chronic conditions, including type 2 diabetes mellitus, and pharmacological therapies that aid weight loss are appealing. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter 2 inhibitors (SGLT2is) are novel glucose-lowering therapies that have been shown to induce clinically significant reductions in body weight. However, this weight loss may not be attributed solely to fat mass (FM). Given the importance of skeletal muscle and lean body mass (LBM) on cardio-metabolic health and physical function, we reviewed the available literature reporting the effects of GLP-1RAs and SGLT2is on body composition. Results demonstrate that, in most circumstances, the weight loss associated with both therapies predominantly comprises a reduction in FM, although significant heterogeneity exists between studies. In over half of the studies identified, the proportion of LBM reduction ranged between 20% and 50% of total weight lost, which is consistent with diet-induced weight loss and bariatric surgery. No clear differences existed between GLP-1RAs and SGLT2is. Consequently, the loss of LBM and skeletal muscle associated with weight loss induced by GLP-1RAs and SGLT2is warrants attention. Strategies to preserve skeletal muscle and improve physical function, for example through structured exercise, are of great importance.

Citations

Citations to this article as recorded by  

• Drug‐related sarcopenia as a secondary sarcopenia
  Masafumi Kuzuya
  Geriatrics & Gerontology International.2024; 24(2): 195.     CrossRef
• Exercise induces tissue-specific adaptations to enhance cardiometabolic health
  Stephen P. Ashcroft, Ben Stocks, Brendan Egan, Juleen R. Zierath
  Cell Metabolism.2024; 36(2): 278.     CrossRef
• Once-weekly semaglutide administered after laparoscopic sleeve gastrectomy: Effects on body weight, glycemic control, and measured nutritional metrics in Japanese patients having both obesity and type 2 diabetes
  Rieko Kanai, Sachiho Kinoshita, Izumi Kanbe, Mariko Sameda, Shuhei Yamaoka, Osamu Horikawa, Yasuhiro Watanabe, Ichiro Tatsuno, Kohji Shirai, Takashi Oshiro, Atsuhito Saiki
  Obesity Pillars.2024; 9: 100098.     CrossRef
• Twenty‐four‐hour physical behaviour profiles across type 2 diabetes mellitus subtypes
  Joseph Henson, Aikaterina Tziannou, Alex V. Rowlands, Charlotte L. Edwardson, Andrew P. Hall, Melanie J. Davies, Thomas Yates
  Diabetes, Obesity and Metabolism.2024; 26(4): 1355.     CrossRef
• The Current Landscape of Pharmacotherapies for Sarcopenia
  Gulistan Bahat, Serdar Ozkok
  Drugs & Aging.2024; 41(2): 83.     CrossRef
• Malnutrition and Sarcopenia as Reasons for Caution with GLP-1 Receptor Agonist Use in HFpEF
  ELISSA DRIGGIN, PARAG GOYAL
  Journal of Cardiac Failure.2024; 30(4): 610.     CrossRef
• Is the GLP-1 receptor agonist, semaglutide, a good option for weight loss in persons with HIV?
  Daniel Lee, Jacqueline Capeau
  AIDS.2024; 38(4): 603.     CrossRef
• Efficacy and safety of tirzepatide, GLP‐1 receptor agonists, and other weight loss drugs in overweight and obesity: a network meta‐analysis
  Xin‐Hui Pan, Bryan Tan, Yip Han Chin, Ethan Cheng Zhe Lee, Gwyneth Kong, Bryan Chong, Martin Kueh, Chin Meng Khoo, Anurag Mehta, Priyanka Majety, Gowtham R. Grandhi, Georgios K. Dimitriadis, Roger Foo, Nicholas W. S. Chew, Carel W. Le Roux, Mamas A. Mamas
  Obesity.2024; 32(5): 840.     CrossRef
• Dual and Triple Incretin-Based Co-agonists: Novel Therapeutics for Obesity and Diabetes
  Robert M. Gutgesell, Rubén Nogueiras, Matthias H. Tschöp, Timo D. Müller
  Diabetes Therapy.2024; 15(5): 1069.     CrossRef
• Malnutrition in real-world patients hospitalized for heart failure with preserved ejection fraction and its potential impact on generalizability of EMPEROR-Preserved trial
  Shinsuke Takeuchi, Takashi Kohno, Ayumi Goda, Yasuyuki Shiraishi, Mike Saji, Yuji Nagatomo, Toshikazu D. Tanaka, Makoto Takei, Shintaro Nakano, Kyoko Soejima, Shun Kohsaka, Tsutomu Yoshikawa
  International Journal of Cardiology.2023; 370: 263.     CrossRef
• Marked weight loss on liraglutide 3.0 mg: Real‐life experience of a Swiss cohort with obesity
  Sara Santini, Nathalie Vionnet, Jérôme Pasquier, Elena Gonzalez‐Rodriguez, Montserrat Fraga, Nelly Pitteloud, Lucie Favre
  Obesity.2023; 31(1): 74.     CrossRef
• Early type 2 diabetes treatment intensification with glucagon‐like peptide‐1 receptor agonists in primary care: An Australian perspective on guidelines and the global evidence
  Roy Rasalam, Sarah Abdo, Gary Deed, Richard O'Brien, Jane Overland
  Diabetes, Obesity and Metabolism.2023; 25(4): 901.     CrossRef
• The effects of weight‐lowering pharmacotherapies on physical activity, function and fitness: A systematic review and meta‐analysis of randomized controlled trials
  Rishi Jobanputra, Jack A. Sargeant, Abdullah Almaqhawi, Ehtasham Ahmad, Franciskos Arsenyadis, David R. Webb, Louisa Y. Herring, Kamlesh Khunti, Melanie J. Davies, Thomas Yates
  Obesity Reviews.2023;[Epub]     CrossRef
• Combination of exercise and GLP-1 receptor agonist treatment reduces severity of metabolic syndrome, abdominal obesity, and inflammation: a randomized controlled trial
  Rasmus M. Sandsdal, Christian R. Juhl, Simon B. K. Jensen, Julie R. Lundgren, Charlotte Janus, Martin B. Blond, Mads Rosenkilde, Adrian F. Bogh, Lasse Gliemann, Jens-Erik B. Jensen, Charalambos Antoniades, Bente M. Stallknecht, Jens J. Holst, Sten Madsbad
  Cardiovascular Diabetology.2023;[Epub]     CrossRef
• Impact of novel glucose‐lowering therapies on physical function in people with type 2 diabetes: A systematic review and meta‐analysis of randomised placebo‐controlled trials
  Ehtasham Ahmad, Franciskos Arsenyadis, Abdullah Almaqhawi, Mary Barker, Rishi Jobanputra, Jack A. Sargeant, David R. Webb, Thomas Yates, Melanie J. Davies
  Diabetic Medicine.2023;[Epub]     CrossRef
• Cancer cachexia as a blueprint for treating obesity
  Nikolai P. Jaschke, Tilman D. Rachner
  Trends in Endocrinology & Metabolism.2023; 34(7): 395.     CrossRef
• The sun is rising on a new era of pharmacotherapy for obesity: some words of caution
  Peter N. Benotti, Bruce R. Bistrian
  Surgery for Obesity and Related Diseases.2023; 19(9): 1075.     CrossRef
• Liraglutide Protects Against Diastolic Dysfunction and Improves Ventricular Protein Translation
  Cody Rutledge, Angela Enriquez, Kevin Redding, Mabel Lopez, Steven Mullett, Stacy L. Gelhaus, Michael Jurczak, Eric Goetzman, Brett A. Kaufman
  Cardiovascular Drugs and Therapy.2023;[Epub]     CrossRef
• Effect of sodium-glucose transporter 2 inhibitors on sarcopenia in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
  Sha Zhang, Zhan Qi, Yidong Wang, Danfei Song, Deqiu Zhu
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Cysteine‐lowering treatment with mesna against obesity: Proof of concept and results from a human phase I, dose‐finding study
  Kathrine J. Vinknes, Thomas Olsen, Hasse Khiabani Zaré, Nasser E. Bastani, Emma Stolt, Anja F. Dahl, Roger D. Cox, Helga Refsum, Kjetil Retterstøl, Anders Åsberg, Amany Elshorbagy
  Diabetes, Obesity and Metabolism.2023; 25(11): 3161.     CrossRef
• Repurposing Drugs for Diabetes Mellitus as Potential Pharmacological Treatments for Sarcopenia – A Narrative Review
  Miles D. Witham, Antoneta Granic, Ewan Pearson, Sian M. Robinson, Avan A. Sayer
  Drugs & Aging.2023; 40(8): 703.     CrossRef
• Introduction to the dietary management of obesity in adults
  Vivian Lee
  Clinical Medicine.2023; 23(4): 304.     CrossRef
• Efficacy and safety of the sodium‐glucose co‐transporter‐2 inhibitor empagliflozin in elderly Japanese adults (≥65 years) with type 2 diabetes: A randomized, double‐blind, placebo‐controlled, 52‐week clinical trial (EMPA‐ELDERLY)
  Daisuke Yabe, Kosuke Shiki, Gosuke Homma, Thomas Meinicke, Yuji Ogura, Yutaka Seino
  Diabetes, Obesity and Metabolism.2023; 25(12): 3538.     CrossRef
• Independent Link Between Use of Mineralocorticoid Receptor Antagonists and Muscle Wasting in Heart Failure Patients Not Receiving Renin-Angiotensin System Inhibitors
  Ryo Numazawa, Satoshi Katano, Toshiyuki Yano, Ryohei Nagaoka, Katsuhiko Ohori, Hidemichi Kouzu, Suguru Honma, Yusuke Fujisawa, Kotaro Yamano, Arata Osanami, Masayuki Koyama, Akiyoshi Hashimoto, Masato Furuhashi
  Circulation Journal.2023; 88(1): 10.     CrossRef
• Sodium-glucose co-transporter 2 inhibitors and Sarcopenia: A controversy that must be solved
  Baris Afsar, Rengin Elsurer Afsar
  Clinical Nutrition.2023; 42(12): 2338.     CrossRef
• Oral semaglutide improves body composition and preserves lean mass in patients with type 2 diabetes: a 26-week prospective real-life study
  Sara Volpe, Giuseppe Lisco, Margherita Fanelli, Davide Racaniello, Valentina Colaianni, Valentina Lavarra, Domenico Triggiani, Lucilla Crudele, Vincenzo Triggiani, Carlo Sabbà, Giovanni De Pergola, Giuseppina Piazzolla
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• The Effects of Sodium–Glucose Cotransporter 2 Inhibitors on Body Composition in Type 2 Diabetes Mellitus: A Narrative Review
  Soodeh Jahangiri, Mojtaba Malek, Sanjay Kalra, Mohammad E. Khamseh
  Diabetes Therapy.2023; 14(12): 2015.     CrossRef
• Relationship between sodium–glucose cotransporter-2 inhibitors and muscle atrophy in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
  Chengdong Xia, Yufeng Han, Chunhui Yin, Ruyue Geng, Zhenfei Liu, Yongle Du, Mingkun Yu
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• The Role of Lifestyle Modification with Second-Generation Anti-obesity Medications: Comparisons, Questions, and Clinical Opportunities
  Thomas A. Wadden, Ariana M. Chao, Molly Moore, Jena S. Tronieri, Adam Gilden, Anastassia Amaro, Sharon Leonard, John M. Jakicic
  Current Obesity Reports.2023; 12(4): 453.     CrossRef
• Sarcopenia and Diabetes: A Detrimental Liaison of Advancing Age
  Giuseppe Lisco, Olga Eugenia Disoteo, Anna De Tullio, Vincenzo De Geronimo, Vito Angelo Giagulli, Fabio Monzani, Emilio Jirillo, Renato Cozzi, Edoardo Guastamacchia, Giovanni De Pergola, Vincenzo Triggiani
  Nutrients.2023; 16(1): 63.     CrossRef
• Novel Antidiabetic Strategies and Diabetologists' Views in Nonalcoholic Steatohepatitis
  Sabine Kahl, Jennifer Pützer, Michael Roden
  Seminars in Liver Disease.2022; 42(01): 048.     CrossRef
• Effect of Empagliflozin Versus Placebo on Body Fluid Balance in Patients With Acute Myocardial Infarction and Type 2 Diabetes Mellitus: Subgroup Analysis of the EMBODY Trial
  Yu Hoshika, Yoshiaki Kubota, Kosuke Mozawa, Shuhei Tara, Yukichi Tokita, Kenji Yodogawa, Yu-Ki Iwasaki, Takeshi Yamamoto, Hitoshi Takano, Yayoi Tsukada, Kuniya Asai, Masaaki Miyamoto, Yasushi Miyauchi, Eitaro Kodani, Mitsunori Maruyama, Jun Tanabe, Wataru
  Journal of Cardiac Failure.2022; 28(1): 56.     CrossRef
• Effect of GLP-1 receptor agonist, liraglutide, on muscle in spontaneously diabetic torii fatty rats
  Shohei Yamada, Yuji Ogura, Kazuho Inoue, Jun Tanabe, Takeshi Sugaya, Keiichi Ohata, Yoshio Nagai, Yasunori Natsuki, Seiko Hoshino, Shiika Watanabe, Daisuke Ichikawa, Kenjiro Kimura, Yugo Shibagaki, Atsuko Kamijo-Ikemori
  Molecular and Cellular Endocrinology.2022; 539: 111472.     CrossRef
• Exendin-4 alleviates steatosis in an in vitro cell model by lowering FABP1 and FOXA1 expression via the Wnt/-catenin signaling pathway
  Olfa Khalifa, Neyla S. AL-Akl, Khaoula Errafii, Abdelilah Arredouani
  Scientific Reports.2022;[Epub]     CrossRef
• Body composition changes at 12 months following different surgical weight loss interventions in adults with obesity: A systematic review and meta‐analysis of randomized control trials
  Amy Sylivris, Jakub Mesinovic, David Scott, Paul Jansons
  Obesity Reviews.2022;[Epub]     CrossRef
• Safety and effectiveness of empagliflozin in Japanese patients with type 2 diabetes: final results of a 3-year post-marketing surveillance study
  Kohei Kaku, Kazuhiro Yamamoto, Yumiko Fukushima, Hristo Lliev, Atsutaka Yasui
  Expert Opinion on Drug Safety.2022; 21(10): 1315.     CrossRef
• Safety and effectiveness of empagliflozin according to body mass index in Japanese patients with type 2 diabetes: a subgroup analysis of a 3-year post-marketing surveillance study
  Kohei Kaku, Kazuhiro Yamamoto, Yumiko Fukushima, Seiko Mizuno, Daisuke Nitta
  Expert Opinion on Drug Safety.2022; 21(11): 1411.     CrossRef
• Le risque de dénutrition chez le sujet âgé diabétique : une limite à l’utilisation des « nouvelles » classes thérapeutiques ?
  Lyse Bordier, Jean Doucet, Bernard Bauduceau
  Médecine des Maladies Métaboliques.2022; 16(5): 422.     CrossRef
• Emerging evidence of the relationship between fat-free mass and ghrelin, glucagon-like peptide-1, and peptide-YY
  Austin J. Graybeal, Jada L. Willis, Elisa Morales-Marroquin, Grant M. Tinsley, Sarah E. Messiah, Meena Shah
  Nutrition.2022; 103-104: 111815.     CrossRef
• The Effectiveness of GLP-1 Receptor Agonist Semaglutide on Body Composition in Elderly Obese Diabetic Patients: A Pilot Study
  Yoshinori Ozeki, Takayuki Masaki, Akari Kamata, Shotaro Miyamoto, Yuichi Yoshida, Mitsuhiro Okamoto, Koro Gotoh, Hirotaka Shibata
  Medicines.2022; 9(9): 47.     CrossRef
• Distribution of lean mass and mortality risk in patients with type 2 diabetes
  Li Ding, Yuxin Fan, Jingting Qiao, Jing He, Ruodan Wang, Qing He, Jingqiu Cui, Zhongshu Ma, Fangqiu Zheng, Hua Gao, Chenlin Dai, Hongyan Wei, Jun Li, Yuming Cao, Gang Hu, Ming Liu
  Primary Care Diabetes.2022; 16(6): 824.     CrossRef
• Cardio-sarcopenia: A syndrome of concern in aging
  De Rong Loh, Ru-San Tan, Wee Shiong Lim, Angela S. Koh
  Frontiers in Medicine.2022;[Epub]     CrossRef
• Type 2 diabetes
  Ehtasham Ahmad, Soo Lim, Roberta Lamptey, David R Webb, Melanie J Davies
  The Lancet.2022; 400(10365): 1803.     CrossRef
• Elevated circulating level of β-aminoisobutyric acid (BAIBA) in heart failure patients with type 2 diabetes receiving sodium-glucose cotransporter 2 inhibitors
  Satoshi Katano, Toshiyuki Yano, Hidemichi Kouzu, Ryohei Nagaoka, Ryo Numazawa, Kotaro Yamano, Yusuke Fujisawa, Katsuhiko Ohori, Nobutaka Nagano, Takefumi Fujito, Ryo Nishikawa, Wataru Ohwada, Masaki Katayose, Tatsuya Sato, Atsushi Kuno, Masato Furuhashi
  Cardiovascular Diabetology.2022;[Epub]     CrossRef
• An overview of anamorelin as a treatment option for cancer-associated anorexia and cachexia
  Guilherme Wesley Peixoto Da Fonseca, Stephan von Haehling
  Expert Opinion on Pharmacotherapy.2021; 22(7): 889.     CrossRef
• Liraglutide Does Not Adversely Impact Fat‐Free Mass Loss
  Andrew Grannell, William P. Martin, Babak Dehestani, Werd Al‐Najim, John C. Murphy, Carel W. le Roux
  Obesity.2021; 29(3): 529.     CrossRef
• Rationale and design of the EMPA-ELDERLY trial: a randomised, double-blind, placebo-controlled, 52-week clinical trial of the efficacy and safety of the sodium–glucose cotransporter-2 inhibitor empagliflozin in elderly Japanese patients with type 2 diabet
  Daisuke Yabe, Kosuke Shiki, Keiko Suzaki, Thomas Meinicke, Yutaro Kotobuki, Kenichiro Nishida, Douglas Clark, Atsutaka Yasui, Yutaka Seino
  BMJ Open.2021; 11(4): e045844.     CrossRef
• Cancer Risk in Normal Weight Individuals with Metabolic Obesity: A Narrative Review
  Bethina Liu, Hugh E. Giffney, Rhonda S. Arthur, Thomas E. Rohan, Andrew J. Dannenberg
  Cancer Prevention Research.2021; 14(5): 509.     CrossRef
• Comprehensive analysis of LncRNAs expression profiles in an in vitro model of steatosis treated with Exendin-4
  Khaoula Errafii, Neyla S. Al-Akl, Olfa Khalifa, Abdelilah Arredouani
  Journal of Translational Medicine.2021;[Epub]     CrossRef
• Dapagliflozin increases the lean-to total mass ratio in type 2 diabetes mellitus
  Vaneza Lira W. Wolf, Ikaro Breder, Luiz Sérgio F. de Carvalho, Alexandre A. S. Soares, Riobaldo M. Cintra, Joaquim Barreto, Daniel B. Munhoz, Sheila T. Kimura-Medorima, Wilson Nadruz, Gil Guerra-Júnior, Thiago Quinaglia, Elza Muscelli, Andrei C. Sposito
  Nutrition & Diabetes.2021;[Epub]     CrossRef
• Optimising the Heart Failure Treatment Pathway: The Role of SGLT2 Inhibitors
  Marc Evans, Angharad R. Morgan, Zaheer Yousef, Gethin Ellis, Umesh Dashora, Dipesh C. Patel, Pam Brown, Wasim Hanif, Johnathan N. Townend, Naresh Kanumilli, Jim Moore, John P. H. Wilding, Stephen C. Bain
  Drugs.2021; 81(11): 1243.     CrossRef
• Glucose-lowering Drugs and Hospitalization for Heart Failure: A Systematic Review and Additive-effects Network Meta-analysis With More Than 500 000 Patient-years
  Riobaldo M Cintra, Ana Claudia Nogueira, Isabella Bonilha, Beatriz M Luchiari, Otavio R Coelho-Filho, Otavio R Coelho, Pedro Schwartzmann, Elza Muscellie, Wilson Nadruz, Luiz Sergio F Carvalho, Andrei C Sposito
  The Journal of Clinical Endocrinology & Metabolism.2021; 106(10): 3060.     CrossRef
• Physical activity and exercise in the management of type 2 diabetes: where to start?
  Deirdre Harrington, Joe Henson
  Practical Diabetes.2021; 38(5): 35.     CrossRef
• Efpeglenatide and Heart and Kidney Outcomes in Type 2 Diabetes
  
  New England Journal of Medicine.2021; 385(22): 2105.     CrossRef
• Effects of Antidiabetic Drugs on Muscle Mass in Type 2 Diabetes Mellitus
  Satoshi Ida, Ryutaro Kaneko, Kanako Imataka, Kaoru Okubo, Yoshitaka Shirakura, Kentaro Azuma, Ryoko Fujiwara, Kazuya Murata
  Current Diabetes Reviews.2021; 17(3): 293.     CrossRef
• Effects of liraglutide and empagliflozin added to insulin therapy in patients with type 2 diabetes: A randomized controlled study
  Hirotatsu Nakaguchi, Yoshinobu Kondo, Mayu Kyohara, Hiromi Konishi, Koji Oiwa, Yasuo Terauchi
  Journal of Diabetes Investigation.2020; 11(6): 1542.     CrossRef
• Sodium Glucose Co-Transporter 2 Inhibition Does Not Favorably Modify the Physiological Responses to Dietary Counselling in Diabetes-Free, Sedentary Overweight and Obese Adult Humans
  Shane P.P. Ryan, Alissa A. Newman, Jessie R. Wilburn, Lauren D. Rhoades, S. Raj J. Trikha, Ellen C. Godwin, Hayden M. Schoenberg, Micah L. Battson, Taylor R. Ewell, Gary J. Luckasen, Laurie M. Biela, Christopher L. Melby, Christopher Bell
  Nutrients.2020; 12(2): 510.     CrossRef
• GLP-1 Receptor Agonist Treatment in Morbid Obesity and Type 2 Diabetes Due to Pathogenic Homozygous Melanocortin-4 Receptor Mutation: A Case Report
  Eva W. Iepsen, Christian T. Have, Simon Veedfald, Sten Madsbad, Jens J. Holst, Niels Grarup, Oluf Pedersen, Ivan Brandslund, Jens-Christian Holm, Torben Hansen, Signe S. Torekov
  Cell Reports Medicine.2020; 1(1): 100006.     CrossRef
• Glucagon‐like peptide 1 infusions overcome anabolic resistance to feeding in older human muscle
  Haitham Abdulla, Bethan E. Phillips, Daniel J. Wilkinson, Marie Limb, Tereza Jandova, Joseph J. Bass, Debbie Rankin, Jessica Cegielski, Mariwan Sayda, Hannah Crossland, John P. Williams, Kenneth Smith, Iskandar Idris, Philip J. Atherton
  Aging Cell.2020;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Forty Years Together, New Leap Forward! The 40th Anniversary of the Korean Endocrine Society
  Jong Chul Won, Ki-Hyun Baek
  Endocrinology and Metabolism.2022; 37(6): 851.     CrossRef

Citations

Citations to this article as recorded by  

• Current utilization patterns for long-acting insulin analogues including biosimilars among selected Asian countries and the implications for the future
  Brian Godman, Mainul Haque, Santosh Kumar, Salequl Islam, Jaykaran Charan, Farhana Akter, Amanj Kurdi, Eleonora Allocati, Muhammed Abu Bakar, Sagir Abdur Rahim, Nusrat Sultana, Farzana Deeba, M. A. Halim Khan, A. B. M Muksudul Alam, Iffat Jahan, Zubair Ma
  Current Medical Research and Opinion.2021; 37(9): 1529.     CrossRef

Citations

Citations to this article as recorded by  

• Enhanced predictive validity of integrative models for refractory hyperthyroidism considering baseline and early therapy characteristics: a prospective cohort study
  Xinpan Wang, Tiantian Li, Yue Li, Qiuyi Wang, Yun Cai, Zhixiao Wang, Yun Shi, Tao Yang, Xuqin Zheng
  Journal of Translational Medicine.2024;[Epub]     CrossRef
• Clinical significance of thyroglobulin antibodies and thyroid peroxidase antibodies in Graves’ disease: a cross-sectional study
  Masahito Katahira, Taku Tsunekawa, Akira Mizoguchi, Mariko Yamaguchi, Kahori Tsuru, Hiromi Takashima, Ryoma Terada
  Hormones.2023; 22(2): 253.     CrossRef
• The Clinical Implications of Anti-thyroid Peroxidase Antibodies in Graves’ Disease in Basrah
  Emad S Alhubaish, Nassar T Alibrahim, Abbas A Mansour
  Cureus.2023;[Epub]     CrossRef
• Influence of Thyroid Peroxidase Antibodies Serum Levels in Graves' Disease: A Retrospective Cohort Study
  Maria L Guia Lopes, Carlos Tavares Bello, José P Cidade, Clotilde Limbert, Joao Sequeira Duarte
  Cureus.2023;[Epub]     CrossRef
• Interpretation of Thyroid Autoantibodies in Hyperthyroidism
  Han-Sang Baek, Dong-Jun Lim
  The Korean Journal of Medicine.2023; 98(3): 132.     CrossRef
• Usefulness of Real-Time Quantitative Microvascular Ultrasonography for Differentiation of Graves’ Disease from Destructive Thyroiditis in Thyrotoxic Patients
  Han-Sang Baek, Ji-Yeon Park, Chai-Ho Jeong, Jeonghoon Ha, Moo Il Kang, Dong-Jun Lim
  Endocrinology and Metabolism.2022; 37(2): 323.     CrossRef
• Differential Diagnosis of Thyrotoxicosis by Machine Learning Models with Laboratory Findings
  Jinyoung Kim, Han-Sang Baek, Jeonghoon Ha, Mee Kyoung Kim, Hyuk-Sang Kwon, Ki-Ho Song, Dong-Jun Lim, Ki-Hyun Baek
  Diagnostics.2022; 12(6): 1468.     CrossRef
• The relationship between atherosclerotic disease and relapse during ATD treatment
  Xinxin Zhu, Yaguang Zhang, Xiaoyu Zhao, Xiaona Zhang, Zixuan Ru, Yanmeizhi Wu, Xu Yang, Boyu Hou, Hong Qiao
  Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
• Programmed Cell Death-Ligand 1 (PD-L1) gene Single Nucleotide Polymorphism in Graves’ Disease and Hashimoto’s Thyroiditis in Korean Patients
  Jee Hee Yoon, Min-ho Shin, Hee Nam Kim, Wonsuk Choi, Ji Yong Park, A Ram Hong, Hee Kyung Kim, Ho-Cheol Kang
  Endocrinology and Metabolism.2021; 36(3): 599.     CrossRef
• Low frequency of IL-10-producing B cells and high density of ILC2s contribute to the pathological process in Graves’ disease, which may be related to elevated-TRAb levels
  Xiaoyun Ji, Jie Wan, Rong Chen, Huixuan Wang, Lan Huang, Shwngjun Wang, Zhaoliang Su, Huaxi Xu
  Autoimmunity.2020; 53(2): 78.     CrossRef
• Implication of VDR rs7975232 and FCGR2A rs1801274 gene polymorphisms in the risk and the prognosis of autoimmune thyroid diseases in the Tunisian population
  S Mestiri, I Zaaber, I Nasr, H Marmouch
  Balkan Journal of Medical Genetics.2020; 23(1): 69.     CrossRef
• Thyroid Peroxidase Antibody Positivity is Associated With Relapse-Free Survival Following Antithyroid Drug Treatment for Graves Disease
  Christopher A. Muir, Graham R.D. Jones, Jerry R. Greenfield, Andrew Weissberger, Katherine Samaras
  Endocrine Practice.2020; 26(9): 1026.     CrossRef
• Predicting the Risk of Graves Disease Relapse: Commentary on “Thyroid Peroxidase Antibody Positivity is Associated with Relapse-Free Survival Following Antithyroid Drug Treatment for Graves Disease”
  D. Gallo, M.L. Tanda, E. Piantanida
  Endocrine Practice.2020; 26(9): 1039.     CrossRef

Citations

Citations to this article as recorded by  

• Enhancing outcome prediction by applying the 2019 WHO DM classification to adults with hyperglycemic crises: A single-center cohort in Thailand
  Chatchon Kaewkrasaesin, Weerapat Kositanurit, Phawinpon Chotwanvirat, Nitchakarn Laichuthai
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2024; 18(4): 103012.     CrossRef
• Obesity and 30-day case fatality after hyperglycemic crisis hospitalizations in Korea: a national cohort study
  Hojun Yoon, Hyun Ho Choi, Giwoong Choi, Sun Ok Song, Kyoung Hwa Ha, Dae Jung Kim
  Cardiovascular Prevention and Pharmacotherapy.2023; 5(3): 74.     CrossRef
• Interpreting global trends in type 2 diabetes complications and mortality
  Mohammed K. Ali, Jonathan Pearson-Stuttard, Elizabeth Selvin, Edward W. Gregg
  Diabetologia.2022; 65(1): 3.     CrossRef
• Comparison of the clinical characteristics and outcomes of pediatric patients with and without diabetic ketoacidosis at the time of type 1 diabetes diagnosis
  Young-Jun Seo, Chang Dae Kum, Jung Gi Rho, Young Suk Shim, Hae Sang Lee, Jin Soon Hwang
  Annals of Pediatric Endocrinology & Metabolism.2022; 27(2): 126.     CrossRef
• Clinical characteristics and outcomes of care in patients hospitalized with diabetic ketoacidosis
  Mohsen S. Eledrisi, Haifaa Alkabbani, Malk Aboawon, Aya Ali, Imad Alabdulrazzak, Maab Elhaj, Ashraf Ahmed, Hazim Alqahwachi, Joanne Daghfal, Salem A. Beshyah, Rayaz A. Malik
  Diabetes Research and Clinical Practice.2022; 192: 110041.     CrossRef
• Hyperglycemic Crisis Characteristics and Outcome of Care in Adult Patients without and with a History of Diabetes in Tigrai, Ethiopia: Comparative Study
  Getachew Gebremedhin, Fikre Enqueselassie, Helen Yifter, Negussie Deyessa
  Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2021; Volume 14: 547.     CrossRef
• Increased Incidence of Pediatric Diabetic Ketoacidosis After COVID-19: A Two-Center Retrospective Study in Korea
  Min Jeong Han, Jun Ho Heo
  Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2021; Volume 14: 783.     CrossRef
• Acute Hyperglycemic Crises with Coronavirus Disease-19: Case Reports
  Na-young Kim, Eunyeong Ha, Jun Sung Moon, Yong-Hoon Lee, Eun Young Choi
  Diabetes & Metabolism Journal.2020; 44(2): 349.     CrossRef
• Letter: Trends in Hyperglycemic Crisis Hospitalizations and in- and out-of-Hospital Mortality in the Last Decade Based on Korean National Health Insurance Claims Data (Endocrinol Metab 2019;34:275–81, Ji Hong You et al.)
  Jang Won Son
  Endocrinology and Metabolism.2019; 34(4): 422.     CrossRef
• Response: Trends in Hyperglycemic Crisis Hospitalizations and in- and out-of-Hospital Mortality in the Last Decade Based on Korean National Health Insurance Claims Data (Endocrinol Metab 2019;34:275–81, Ji Hong You et al.)
  Ji Hong You, Sun Ok Song
  Endocrinology and Metabolism.2019; 34(4): 424.     CrossRef

Citations

Citations to this article as recorded by  

• Risk of Cause-Specific Mortality across Glucose Spectrum in Elderly People: A Nationwide Population-Based Cohort Study
  Joonyub Lee, Hun-Sung Kim, Kee-Ho Song, Soon Jib Yoo, Kyungdo Han, Seung-Hwan Lee
  Endocrinology and Metabolism.2023; 38(5): 525.     CrossRef
• Comparison of on-Statin Lipid and Lipoprotein Levels for the Prediction of First Cardiovascular Event in Type 2 Diabetes Mellitus
  Ji Yoon Kim, Jimi Choi, Sin Gon Kim, Nam Hoon Kim
  Diabetes & Metabolism Journal.2023; 47(6): 837.     CrossRef
• Effectiveness of quality of care for patients with type 2 diabetes in China: findings from the Shanghai Integration Model (SIM)
  Chun Cai, Yuexing Liu, Yanyun Li, Yan Shi, Haidong Zou, Yuqian Bao, Yun Shen, Xin Cui, Chen Fu, Weiping Jia
  Frontiers of Medicine.2022; 16(1): 126.     CrossRef
• Comparison of Health Outcomes by Care Provider Type for Newly Diagnosed Mild Type 2 Diabetes Patients in South Korea: A Retrospective Cohort Study
  Hee-Chung Kang, Jae-Seok Hong
  Healthcare.2022; 10(2): 334.     CrossRef
• Management Status of Patients with Type 2 Diabetes Mellitus at General Hospitals in Korea: A 5-Year Follow-Up Study
  Jin Hee Jung, Jung Hwa Lee, Hyang Mi Jang, Young Na, Hee Sun Choi, Yeon Hee Lee, Yang Gyo Kang, Na Rae Kim, Jeong Rim Lee, Bok Rye Song, Kang Hee Sim
  The Journal of Korean Diabetes.2022; 23(1): 64.     CrossRef
• Type 2 Diabetes Mellitus with Early Dry Skin Disorder: A Comparison Study Between Primary and Tertiary Care in Indonesia
  Lili Legiawati, Kusmarinah Bramono, Wresti Indriatmi, Em Yunir, Aditya Indra Pratama
  Current Diabetes Reviews.2022;[Epub]     CrossRef
• Long-Term Changes in HbA1c According to Blood Glucose Control Status During the First 3 Months After Visiting a Tertiary University Hospital
  Hyunah Kim, Da Young Jung, Seung-Hwan Lee, Jae-Hyoung Cho, Hyeon Woo Yim, Hun-Sung Kim
  Journal of Korean Medical Science.2022;[Epub]     CrossRef
• Differences in health behavior and nutrient intake status between diabetes-aware and unaware Korean adults based on the Korea national health and nutrition examination survey 2016–18 data: A cross-sectional study
  Anshul Sharma, Chen Lulu, Kee-Ho Song, Hae-Jeung Lee
  Frontiers in Public Health.2022;[Epub]     CrossRef
• Effects of Diabetes Quality Assessment on Diabetes Management Behaviors Based on a Nationwide Survey
  Chang Kyun Choi, Jungho Yang, Ji-An Jeong, Min-Ho Shin
  International Journal of Environmental Research and Public Health.2022; 19(23): 15781.     CrossRef
• The Impact of the Indonesian Chronic Disease Management Program (PROLANIS) on Metabolic Control and Renal Function of Type 2 Diabetes Mellitus Patients in Primary Care Setting
  Firas Farisi Alkaff, Fauzan Illavi, Sovia Salamah, Wiwit Setiyawati, Ristra Ramadhani, Elly Purwantini, Dicky L. Tahapary
  Journal of Primary Care & Community Health.2021; 12: 215013272098440.     CrossRef
• Questionnaire-based Survey of Demographic and Clinical Characteristics, Health Behaviors, and Mental Health of Young Korean Adults with Early-Onset Diabetes
  Ji In Park, Hyunjeong Baek, Sang-Wook Kim, Ji Yun Jeong, Kee-Ho Song, Ji Hee Yu, Il Sung Nam-Goong, Eun-Hee Cho
  Journal of Korean Medical Science.2021;[Epub]     CrossRef
• Sodium–Glucose Cotransporter 2 Inhibitors and Risk of Retinal Vein Occlusion Among Patients With Type 2 Diabetes: A Propensity Score–Matched Cohort Study
  Min-Kyung Lee, Bongsung Kim, Kyungdo Han, Jae-Hyuk Lee, Minhee Kim, Mee Kyoung Kim, Ki-Hyun Baek, Ki-Ho Song, Hyuk-Sang Kwon, Young-Jung Roh
  Diabetes Care.2021; 44(10): 2419.     CrossRef
• Challenges in the Management of Diabetes in Primary Care
  Yeon Kyung Lee
  The Journal of Korean Diabetes.2020; 21(3): 161.     CrossRef
• Does Diabetes Increase the Risk of Contracting COVID-19? A Population-Based Study in Korea
  Sung-Youn Chun, Dong Wook Kim, Sang Ah Lee, Su Jung Lee, Jung Hyun Chang, Yoon Jung Choi, Seong Woo Kim, Sun Ok Song
  Diabetes & Metabolism Journal.2020; 44(6): 897.     CrossRef
• Comprehensive Efforts Are Needed to Improve the Quality of Primary Diabetes Care in Korea
  Chan-Hee Jung
  Endocrinology and Metabolism.2019; 34(3): 265.     CrossRef

Citations

Citations to this article as recorded by  

• Aldosterone Inhibits In Vitro Myogenesis by Increasing Intracellular Oxidative Stress via Mineralocorticoid Receptor
  Jin Young Lee, Da Ae Kim, Eunah Choi, Yun Sun Lee, So Jeong Park, Beom-Jun Kim
  Endocrinology and Metabolism.2021; 36(4): 865.     CrossRef

Citations

Citations to this article as recorded by  

• Increased proliferation and neuronal fate in prairie vole brain progenitor cells cultured in vitro: effects by social exposure and sexual dimorphism
  Daniela Ávila-González, Italo Romero-Morales, Lizette Caro, Alejandro Martínez-Juárez, Larry J. Young, Francisco Camacho-Barrios, Omar Martínez-Alarcón, Analía E. Castro, Raúl G. Paredes, Néstor F. Díaz, Wendy Portillo
  Biology of Sex Differences.2023;[Epub]     CrossRef
• Anterior pituitary gland synthesises dopamine from l‐3,4‐dihydroxyphenylalanine (l‐dopa)
  Santiago Jordi Orrillo, Nataly de Dios, Antonela Sofía Asad, Fernanda De Fino, Mercedes Imsen, Ana Clara Romero, Sandra Zárate, Jimena Ferraris, Daniel Pisera
  Journal of Neuroendocrinology.2020;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Research status and prospects of pituitary adenomas in conjunction with neurological and psychiatric disorders and the tumor microenvironment
  Siyuan Cui, Sainan Chen, Xuechao Wu, Qing Wang
  Frontiers in Neuroscience.2024;[Epub]     CrossRef
• Immune landscape and progress in immunotherapy for pituitary neuroendocrine tumors
  Xiaopeng Guo, Yiying Yang, Zhihong Qian, Mengqi Chang, Yuanli Zhao, Wenbin Ma, Yu Wang, Bing Xing
  Cancer Letters.2024; : 216908.     CrossRef
• Transcriptome of GH-producing pituitary neuroendocrine tumours and models are significantly affected by somatostatin analogues
  Rihards Saksis, Olesja Rogoza, Helvijs Niedra, Kaspars Megnis, Ilona Mandrika, Inga Balcere, Liva Steina, Janis Stukens, Austra Breiksa, Jurijs Nazarovs, Jelizaveta Sokolovska, Ilze Konrade, Raitis Peculis, Vita Rovite
  Cancer Cell International.2023;[Epub]     CrossRef
• PD-L1 Expression in Pituitary Neuroendocrine Tumors/Pituitary Adenomas
  Giulia Cossu, Stefano La Rosa, Jean Philippe Brouland, Nelly Pitteloud, Ethan Harel, Federico Santoni, Maxime Brunner, Roy Thomas Daniel, Mahmoud Messerer
  Cancers.2023; 15(18): 4471.     CrossRef
• Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways
  Simona Serioli, Ludovico Agostini, Alberto Pietrantoni, Federico Valeri, Flavia Costanza, Sabrina Chiloiro, Barbara Buffoli, Amedeo Piazza, Pietro Luigi Poliani, Maria Peris-Celda, Federica Iavarone, Simona Gaudino, Marco Gessi, Giovanni Schinzari, Pier P
  International Journal of Molecular Sciences.2023; 24(21): 15719.     CrossRef
• Muti-omics integration analysis revealed molecular network alterations in human nonfunctional pituitary neuroendocrine tumors in the framework of 3P medicine
  Siqi Wen, Chunling Li, Xianquan Zhan
  EPMA Journal.2022; 13(1): 9.     CrossRef
• A systematic review of molecular alterations in invasive non-functioning pituitary adenoma
  Nazanin Hosseinkhan, Maryam Honardoost, Zahra Emami, Sara Cheraghi, Nahid Hashemi-Madani, Mohammad E. Khamseh
  Endocrine.2022; 77(3): 500.     CrossRef
• Medication for Acromegaly Reduces Expression of MUC16, MACC1 and GRHL2 in Pituitary Neuroendocrine Tumour Tissue
  Rihards Saksis, Ivars Silamikelis, Pola Laksa, Kaspars Megnis, Raitis Peculis, Ilona Mandrika, Olesja Rogoza, Ramona Petrovska, Inga Balcere, Ilze Konrade, Liva Steina, Janis Stukens, Austra Breiksa, Jurijs Nazarovs, Jelizaveta Sokolovska, Valdis Pirags,
  Frontiers in Oncology.2021;[Epub]     CrossRef
• Large Scale Molecular Studies of Pituitary Neuroendocrine Tumors: Novel Markers, Mechanisms and Translational Perspectives
  Raitis Peculis, Helvijs Niedra, Vita Rovite
  Cancers.2021; 13(6): 1395.     CrossRef
• Nkx3-1 and Fech genes might be switch genes involved in pituitary non-functioning adenoma invasiveness
  Nasibeh Khayer, Maryam Jalessi, Amin Jahanbakhshi, Alireza Tabib khooei, Mehdi Mirzaie
  Scientific Reports.2021;[Epub]     CrossRef
• The tumour microenvironment of pituitary neuroendocrine tumours
  Pedro Marques, Ashley B. Grossman, Márta Korbonits
  Frontiers in Neuroendocrinology.2020; 58: 100852.     CrossRef
• The Progress of Immunotherapy in Refractory Pituitary Adenomas and Pituitary Carcinomas
  Congxin Dai, Siyu Liang, Bowen Sun, Jun Kang
  Frontiers in Endocrinology.2020;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Five-year follow-up results of thermal ablation for benign thyroid nodules: Systematic review and meta-analysis
  Xidong Xu, Ying Peng, Guoxin Han
  American Journal of Otolaryngology.2024; 45(1): 104025.     CrossRef
• How to Monitor and Manage Nodule Regrowth after Thermal Ablation of Benign Thyroid Nodules
  Sang Ik Park, Jung Hwan Baek
  Korean Journal of Radiology.2021; 22(2): 293.     CrossRef